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Abstract of Dissertation 
 
Structural Insights Into RNA Splicing 
 
by 
 
Jessica K. Peters 
 
Doctor of Philosophy in Chemistry 
 
University of California, San Diego, 2017 
 
Professor Navtej Toor, Chair 
 
 The formation of branched lariat RNA is an evolutionarily conserved feature of 
RNA splicing reactions for both group II and spliceosomal introns. In both splicing 
systems, the lariat is formed in the first of two transesterification reactions as a result of 
the 2' hydroxyl of a conserved bulged adenosine within the intron attacking the 
phosphate backbone at the 5' splice site. In the second step, the 3' hydroxyl of the 5' 
exon attacks the 3' splice site, resulting in ligation of the exons and release of the intron 
as a lariat. Due to the mechanistic and structural similarities, it is believed that group II 
 xxi 
introns and the spliceosome share a common ancestor. Though many structures have 
been published of both group II introns and the spliceosome, the precise structural 
requirements for splicing in both systems remain unknown. In the case of group II 
introns, all of the structures published prior to the work in this dissertation are of a 
primitive group IIC intron from the bacterium Oceanobacillus iheyensis (O.i.). This 
intron splices through a hydrolytic pathway and therefore does not provide a 
comprehensive understanding of branch formation, which severely limits the 
conclusions that can be applied to our understanding of the spliceosome. This 
dissertation describes various experiments that have been performed to better 
understand how group II introns and the RNA components of the spliceosome active 
site are able to properly fold and place substrates within the single active site for the two 
subsequent reactions.  
 Two new crystal structures of the lariat-forming IIB intron from the brown algae 
Pylaiella litoralis, P.li.LSUI2, at different stages of splicing are outlined in this 
dissertation: the intermediate lariat–3' exon and post-catalytic lariat. Two different 
arrangements of the catalytic triplex, the residues which create the active site scaffold, 
are observed in these structures. However, examination of all published O.i. crystal 
structures reveals the same catalytic triplex arrangement throughout splicing. Therefore, 
the rearrangement that occurs in the more evolved P.li.LSUI2 intron is likely facilitating 
the transition between the stages of splicing and relevant to branch formation and exon 
ligation in the spliceosome. These structures are also the first in which domain VI is 
visualized. Domain VI is integral to the branching pathway as it contains the first-step 
 xxii 
nucleophilic residue. For the first time, domain II can be seen forming two tetraloop-
receptor interactions, p-p' and h-h', with domain VI proximal to the bulged adenosine. 
These tertiary interactions appear to stabilize domain VI. However, disrupting either or 
both interactions simultaneously results in a stalling of the second step. Additionally, 
iridium hexammine binds in the major groove of domain VI and promotes exon ligation. 
Taken together, this suggests that domain VI is dynamic and plays an important role in 
facilitating both steps of splicing. 
  1 
Chapter 1: Introduction 
 
1.1 Discovery of group II introns 
 When RNA research became popular in the mid-1900s, it was thought that RNA 
played only three major roles within cells: 1) as the translatable message containing our 
genetic information (mRNA), 2) as the structural framework of the ribosome (rRNA), 
and 3) as the scaffold linking amino acid building blocks to the genetic code (tRNA). 
Carl Woese, Francis Crick, and Leslie Orgel originally proposed the idea that RNA 
could play another important role as catalysts in 19681–3, but it wasn’t until 1982 that 
evidence was found for such RNAs. Catalytic RNAs, or ribozymes, were discovered in 
the early 1980s by Tom Cech4,5 and Sid Altman6, an achievement which awarded them 
the Nobel Prize in chemistry in 1989. Their introduction of the idea that RNAs could 
catalyze reactions, a macromolecular role previously thought only to be held by 
proteins, led to the discovery of many more catalytic RNAs. Over the next few decades, 
RNAs were discovered or created with a broad range of functions including self-
cleavage4,5,7–9, cyclization10, polymerization11, branching12, tRNA processing6, and 
many more.  
 The particular catalytic RNA discovered by Tom Cech was a self-splicing intron 
RNA from the protozoan Tetrahymena thermophila. This class of RNA catalyzes its 
self-removal from flanking exon sequences through two transesterification reactions 
utilizing an exogenous guanosine as the nucleophile in the first step (Figure 1.1). As a 
true ribozyme, this intron does this in the absence of any proteins. Shortly after this 
discovery, more self-cleaving introns were found interrupting genes in the mitochondria 
  
2 
of yeast and fungi13. Although these introns were also capable of splicing in the absence 
of proteins, they did not share any sequence homology with group I introns. 
Investigation of Saccharomyces cerevisiae mitochondrial RNAs using electron 
microscopy revealed covalent circular intron RNA products (Figure 1.2) similar to those 
produced by the spliceosome14. This was particularly interesting because mitochondria 
do not contain spliceosomal introns or the machinery to remove them. This circular 
product, later referred to as a lariat, provided evidence for a new class of auto-catalytic 
introns more closely related to spliceosomal introns. Based on this and phylogenetic 
analyses, these auto-catalytic introns have been classified as group I and group II 
introns.  
 
 
  
3 
 
Figure 1.1: Mechanism of splicing in three splicing systems. 5′ exon is shown in blue, 
3′ exon in yellow, intron in pink, and 1st step nucleophile in green. left) Group I intron 
splicing proceeds via nucleophilic attack of the 3′ OH of an exogenous guanosine. In 
the next reaction, the 3′ OH of the 5′ exon attacks the 3’ splice site. middle) Group II 
intron splicing proceeds via nucleophilic attack of the 2′ OH of a conserved adenosine. 
The second step proceeds as in group I introns. right) Spliceosomal splicing proceeds 
identically to group II introns except that the complex is composed of both RNA and 
proteins. Taken from Biochemistry, 7th Ed15. 
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Figure 1.2: Electron micrographs showing Saccharomyces cerevisiae 
mitochondrial RNA. 1) Randomly selected field of ~1Kb RNA contains both circular 
(indicated with arrows) and linear RNAs. Circular RNAs are assumed to be covalent 
products because they persist in harsh denaturing conditions (70% formamide at 80°C). 
2-4) Fields selected to show circular RNAs. The bars represent 0.25 µm. Taken from 
Halbreich et al14. 
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 Though both group I and group II introns splice via two sequential 
transesterification reactions, the nucleophile for the first step is different (Figure 1.1). 
In group II introns, the nucleophile for the first step is the 2′ hydroxyl of a conserved 
adenosine near the 3′ end of the intron, whereas in group I introns it is the 3′ hydroxyl 
of an exogenous guanosine. Therefore, group I intron splicing results in a linear intron 
whereas group II intron splicing results in a lariat intron with a unique 2′-5′ bond 
between the first intron nucleotide and the conserved adenosine16,17. The second step 
proceeds the same in the self-splicing systems: the 3′ hydroxyl of the 5′ exon attacks the 
3′ splice site resulting in ligated exons and a free intron. Spliceosome-catalyzed splicing 
follows the same mechanism as group II introns, however it is both protein- and ATP-
dependent. In addition, both transesterification reactions are chemically identical in 
group II introns and the spliceosome with regard to their scissile phosphate Rp and Sp 
dependencies18–21. The unique lariat bond in these systems also allows for reverse-
splicing and, in the case of group II introns, retrotransposition22–24.  
 
1.2 Phylogenetic classification of group II introns 
 Group II introns are found in all three domains of life, though are rarely found 
in archaea25,26. Within eukarya, group II introns are limited to the organellar genomes 
of plants, fungi, protists, and an annelid worm27–30. Some group II introns contain and 
open reading frame (ORF) that codes for an intron-encoded protein (IEP), or maturase31. 
The IEP is a multifunctional protein that plays two roles. First, it binds to the RNA to 
stabilize the overall structure and promote splicing. Next, it remains bound to the intron 
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RNA to facilitate invasion of DNA through the reverse splicing activity of the intron 
and the reverse transcriptase activity of the IEP. As long as the ribozyme remains active 
and associated with its IEP, it can continuously invade DNA with minimal disruption 
of gene expression. Nearly all (>99%) of group II introns in bacteria encode an IEP32. 
However, group II introns in the organelles of lower eukaryotes more commonly contain 
degenerate ribozymes, lack an IEP, or encode degenerate IEPs no longer capable of 
intron mobility13,33–36. Bacterial group II introns are typically inserted intergenically, 
whereas nearly all organellar group II introns are located within housekeeping genes. In 
the case of organellar group II introns, their ability to splice is critical to the host’s 
survival. Because these introns are often degenerate or immobile, they have adapted to 
use host-supplied splicing factors34,37,38.   
 Group II introns are subdivided into three classes based on secondary structure 
and exon recognition: IIA, IIB, and IIC (Figure 1.3). All classes can be found in bacteria, 
whereas only IIA introns have been found in mitochondrial genomes and IIB introns in 
chloroplast genomes39. Of the three, IIC introns are thought to be the most primitive25. 
They are significantly smaller than IIA/B introns (400 vs. 600-800 nucleotides), and 
they contain a different catalytic triad sequence than IIA/B introns and the spliceosome 
(CGC vs. AGC)40. IIA and IIB introns typically form large amounts of lariat RNA 
during in vitro self-splicing reactions, whereas IIC introns primarily splice through 
hydrolysis in vitro to form linear intron41. Additionally, IIC introns tend to be more 
promiscuous in their 5′ and 3′ splice site selections in vitro, often resulting in internal 
cleavage products41. It is only with the addition of an IEP that the IIC intron 
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predominantly forms lariat, indicating that IIC introns exhibit a much less stable RNA 
fold42.  
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Figure 1.3: The three subclasses of group II introns. (a) Secondary structure diagrams 
of the three subclasses of group II introns. The 6 domains are numbered D1-D6. Long-
range tertiary contacts are color-coded and labeled with Greek letters. EBS: exon-
binding site; IBS: intron-binding site; ORF: open reading frame. Taken from Zhao and 
Pyle, 201743. (b) Base-pairing interactions used in exon recognition of each subclass.  
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1.3 The structure that begets function in group II introns 
 Group II introns can be easily recognized by their characteristic secondary 
structure in which six domains (DI-DVI) emanate out from a central hub like spokes on 
a wheel (Figure 1.4). DI, the largest of the six domains and located at the 5′ end of the 
intron, acts as a scaffold upon which the remainder or the ribozyme folds. It also 
contains sequences that base-pair with the 5′ and 3′ exons to correctly position them in 
the active site for catalysis44. DII participates in four tetraloop-receptor interactions 
within the intron, most important of which are the two with DVI that are implicated to 
be dynamic throughout splicing45. DIII acts as a structural brace in a manner similar to 
an architectural buttress. DIV encodes the ORF for the IEP. DV contains the highly 
conserved catalytic triad and two-nucleotide bulge that form the active site and properly 
position the two catalytic Mg2+, therefore awarding it the title of “catalytic domain.” 
DVI, located at the 3′ end of the intron, contains the conserved bulged adenosine that 
acts as the nucleophile during the first step of splicing.  
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Figure 1.4: Secondary structure of an unspliced group IIB intron. The intron is 
organized into six domains, listed as DI-DVI, radiating out from a central hub. Long-
range tertiary interactions are indicated in Greek letters. Coloring is consistent with 
published group II intron crystal structures. DI is shown as green, purple, orange, grey, 
and cyan. DII is shown as blue. DIII is shown as yellow. DVI is shown as wheat with 
the open reading frame as a dashed line. DV is shown as red. DVI is shown as magenta. 
The 5′ exon is shown as sky blue. The 3′ exon is shown as gold.  
 
 Depending on the intron subclass, there are between 7 and 12 known tertiary 
interactions that stabilize the ribozyme architecture, the vast majority of which involve 
DI. As mentioned, DI contains sequences, referred to as exon binding sequences (EBS), 
which pair with both the 5′ (EBS1 and EBS2) and 3′ exon (EBS3) to properly position 
them within the active site during the different stages of splicing. Additionally, a base-
pairing interaction between DI and residues 3 and 4 at the conserved 5′ end of the intron 
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(GUGYG) also forms to correctly position the 5′ splice site (e-e′). Disruption of this 
interaction results in decreased splicing efficiency that can be recovered with 
compensatory mutations46.  
 Two kissing loop interactions, a-a′44 and b-b′47, present within DI are thought 
to be among the first tertiary contacts to form during ribozyme folding48. Though the 
sequence and length of these interactions is not conserved, evidence of their coevolution 
suggests an importance to the overall architecture of the ribozyme40. In fact, disruption 
of a-a′ results in defective splicing49. It is likely that a-a′ and b-b′ are integral to the 
proper folding of DI, upon which the remainder of the ribozyme folds. Once the 
ribozyme has folded to a near-native state, crucial inter-domain contacts form48. The 
two tetralooop-receptor interactions between DI and DV, k-k′50 and z-z′33, are 
positioned at opposite ends of DV to create a ~45° bend in DV at the two-nucleotide 
bulge51. This bend allows the two-nucleotide bugle to properly interact with the catalytic 
triad and coordinate the two catalytic Mg2+ within the active site. Interestingly, DI and 
DV alone can be combined to form a minimal group II ribozyme that is capable of some 
form of catalytic activity, though it is much lower than wild type52,53.  This highlights 
the crucial role DI plays as a scaffold that is key to correctly positioning active site 
residues.  
 DII has a “Y” shaped secondary structure with two inter-domain tertiary contacts 
in the stem (t-t′ and q-q′) and one contact in each arm (h-h′ and p-p′) for a total of 4 
contacts. In a recent crystal structure of a IIB intron, the two arms of the DII “Y” are 
coaxially stacking alongside DVI, allowing for both the h-h′54 and p-p′45 tetraloop-
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receptor interactions to be docked45. Deleting DII was shown to have no effect on the 
first splicing reaction, but resulted in an inhibition of the second reaction54. Because of 
this, it was hypothesized that DVI was undocked for the first step, then underwent a 
large-scale ratcheting movement to dock into DII for the second step55. However, low 
resolution crystallographic data of the same intron in the pre-catalytic state suggests that 
h-h′ is engaged prior to branching45. Therefore, a new model of DVI rearrangements 
has been proposed to incorporate evidence that h-h′ is constant and p-p′ is dynamic (see 
Chapter 5).  
 DIII size and shape varies, but is conserved within each subclass. The most 
complex DIII structure is within the group IIB introns. In this class, DIII contains an 
internal loop followed by a three-way junction of three stem loops. There are three 
known tertiary interactions in which DIII participates: r-r′45 (with DI), t-t′45 (with DII), 
and µ-µ′56 (with DV). The deletion or mutagenesis of this domain results in a much 
lower splicing efficiency which can be restored with the addition of DIII in trans57,58. 
Therefore, it has been referred to as a “catalytic effector” for group II intron splicing as 
its presence dramatically increases the rate of splicing57,59,60. Recent crystal structures 
have shed light on how DIII is able to have such a strong effect on catalysis when it is 
not directly interacting with the substrates or active site. We now know that the µ-µ′ 
interaction is positioned on the opposite side of DV from the active site likely serving 
to brace DV, and the t-t′ interaction with DII appears to stabilize the side of DII opposite 
from DVI45. 
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 In the secondary structure, the six domains are connected via single-stranded 
junction nucleotides. The length of these junctions is variable among the subclasses, 
with IIC introns containing the shortest sequences. The junction between domains II 
and III (J2/3) is of particular importance because it forms two crucial tertiary contacts. 
The first contact made by J2/3 is between a single nucleotide in the middle of J2/3, g, 
and the final nucleotide of the intron, g′. These residues have coevolved to form a 
Watson-Crick base pair that is required for the second step of splicing46. Mutagenesis 
of this interaction has been shown to severely decrease the rate and fidelity of the second 
step61,62. The g-g′ interaction likely works with the IBS3-EBS3 (or d-d′ in IIA introns) 
base-pairing interaction to correctly position the 3′ splice site in the active site with a 
kinked backbone to facilitate splicing. The second tertiary contact made by J2/3 is from 
the two conserved nucleotides immediately downstream of g that participate in base 
triples with the first two nucleotides of the catalytic triad in DV51,63,64. Deletion of these 
two nucleotides results in a dramatic inhibition of the second step of splicing, likely 
because their removal alters the placement of the g nucleotide and makes it unable to 
pair with g′.  
 Previously, a crystal structure of a hydrolytic IIC intron from the bacterium 
Oceanobacillus iheyensis (O. iheyensis) revealed that the highly conserved DV forms 
an active site containing two catalytic magnesium ions51. Consecutive base triples 
consisting of nucleotides from the catalytic triad, DV two-nucleotide bulge, J2/3, and 
J4/5 form the catalytic triplex, which makes up the scaffold for the active site and 
catalytic Mg2+ binding. This organization was first observed in the crystal structure of a 
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hydrolytic IIC intron from the bacterium Oceanobacillus iheyensis (O. iheyensis)51 and 
then later in a lariat-forming IIB intron from the brown algae Pylaiella littoralis 
(P.li.LSUI2)45, though the O. iheyensis catalytic triplex did not contain J4/5 nucleotides 
as this intron lacks a junction sequence between domains IV and V.  
 DVI is the final domain of intron and contains the conserved bulged adenosine 
required for lariat formation in the first step65. It was first visualized in 2014 in the 
crystal structure of the P.li.LSUI2 intron45. Given that this intron catalyzes lariat 
formation66, it has contributed to a new understanding of the structural requirements for 
splicing in higher eukaryotes. Mutagenesis of the branch-site nucleotide indicates that 
alterations of the base identity are tolerated, and splicing proceeds with no apparent loss 
of fidelity but at a much slower rate67. The location of the branch-site nucleotide with 
respect to the base of the stem and the catalytic triad of DV is also strictly enforced, 
with the ideal arrangement being a 3-nt J5/6 and a 4-bp stem at the base of DVI68.  
 
1.4 The evolution of group II introns and similarities to the 
spliceosome 
 It has been shown that a single group II intron sequence could be fragmented 
into two or three segments and assembled to trans-splice both in vitro and in vivo, 
indicating a modular structural arrangement of these introns47,53,69–72. In fact, naturally 
occurring bipartite and tripartite group II intron systems have been found in plant 
mitochondria and plant/algal chloroplasts in which separate precursor mRNAs form one 
intermolecular structure to splice and join exon sequences from the different 
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transcripts73. This provides strong evidence that spliceosomal introns may have evolved 
from the retrotransposition of group II introns.  
 Figure 1.5 shows the current hypothesis of how group II introns evolved into the 
eukaryotic introns that are removed by the spliceosome. It is thought that after symbiosis 
of single-celled prokaryotes into an archaebacterial host, intron sequences then became 
a part of the host genome through group II introns retrotransposition and genome 
transfer following endosymbiont lysis. Gene expression was likely impeded by 
translation of unspliced transcripts and co-transcriptional translation, which then 
provided evolutionary pressure to develop a nuclear envelope and a more efficient 
system to remove introns (i.e., the spliceosome). Fragmentation of group II introns in 
organelles led to trans-splicing ribozymes, whereas fragmentation in the nucleus led to 
the spliceosome.  
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Figure 1.5: Endosymbiont event and origin of spliceosomal introns. Eukaryotes are 
thought to have evolved through the symbiosis of prokaryotes (endosymbiont event. 
Archaebacterial hosts likely engulfed prokaryotic symbionts that would later evolve into 
mitochondria and chloroplasts. Horizontal gene transfer and group II intron invasion 
then resulted in altering of the host genome. Formation of the nuclear envelope then led 
to the evolution of the spliceosome to remove introns before nuclear export and 
translation could occur.  
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 The spliceosome is a multi-megadalton complex consisting of 5 snRNAs and up 
to 150 associated proteins in humans74,75. It catalyzes the removal of introns through 
two sequential transesterification reactions in a mechanism chemically identical to the 
one occurring in group II introns20,21,76. Recent biochemical evidence has also shown 
that the spliceosome is a ribozyme that uses a two-metal-ion mechanism of catalysis77. 
Two spliceosomal RNAs, U2 and U6, comprise the active site and are capable of 
performing a splicing-related reaction in the absence of spliceosomal proteins78,79. The 
core RNA architecture of both systems is quite similar (Figure 1.6), and high resolution 
cryo-EM structures of the spliceosome reveal a nearly identical active site 
architecture80–83. The snRNA U6 forms an internal stem loop that is almost 
indistinguishable from the fold of DV in group II introns. Lastly, the sequence 
homology and crystal structure of spliceosomal protein Prp8 indicate that this protein 
very likely evolved from a group II IEP84.  
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Figure 1.6: Comparison of the group II intron ribozyme and spliceosomal snRNA 
structure. (top) Group IIA intron secondary structure diagram. (bottom) Secondary 
structure pairing of snRNAs U2/U6 and U5. Non-analogous RNA sequences (dashed 
red lines) are omitted for clarity. Taken from McNeil et al. (2016)85. 
 
1.5 Goal of the dissertation 
 Though previous crystal structures of the group IIC intron from the bacterium 
Oceanobacillus iheyensis provided important structural understanding of group II intron 
folding and active site architecture, this intron is primitive and does not form lariat in 
the absence of its associated maturase protein. Therefore, the group II intron structural 
studies performed prior to this dissertation do not contribute to the understanding of 
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splicing via the branching pathway. This pathway is more relevant as it is the pathway 
used by the spliceosome and group II introns in their in vivo environments. The 
following chapters outline work done to elucidate the structural requirements for 
branching and exon ligation in lariat-forming group II introns and the spliceosome.  
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Chapter 2: Determination of the U2/U6 snRNA crystal 
structure 
 
2.1 Abstract 
 The spliceosome is the eukaryotic ribonucleoprotein (RNP) complex 
responsible for the removal, or splicing, or introns from pre-mRNA to form mature 
mRNA. Virtually all genes undergo alternative splicing to produce multiple protein 
isoforms, thus increasing coding capacity. The complexity of the spliceosome 
(5snRNAs and over 150 associated proteins) makes it difficult to study structurally. U2 
and U6, which are highly conserved, are thought to form the active site because they are 
the only snRNAs required for both steps of splicing, and they are capable of catalysis in 
the absence of any proteins. The active site of group II introns is composed of conserved 
RNA sequences equivalent to U2 and U6, and they both share a similar mechanism of 
splicing. Crystallization experiments of a U2-U6 snRNA complex have resulted in 
crystals that diffract to a resolution of 1.8–2.9 Å. Heavy metal soaks with YbCl3 reveal 
two anomalous peaks ~4.3 Å apart, which is indicative of a two-metal ion mechanism 
of catalysis.  
 
2.2 Introduction 
 The spliceosome, an incredibly dynamic ribonucleoprotein (RNP), removes 
introns from flanking exon sequences through two sequential transesterification 
reactions (branching and exon ligation). This process is exceedingly complex, involving 
5 snRNAs and up to 150 associated proteins in humans1,2. To make matters more 
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complex, both branching and exon ligation take place within a single active site, 
necessitating a rearrangement of products and reactants between the reactions. How the 
spliceosome is able to sense the progression of splicing and induce the correct structural 
rearrangements remains unclear. Although proteins play an important role both 
structurally and in promoting catalysis3,4, the catalytic core itself is composed of the 
snRNAs U2 and U65–8. In fact, it has been shown that these two snRNAs are capable of 
catalyzing both steps of splicing in vitro in the absence of spliceosomal proteins9–11.  
 Until recently, the complex and dynamic nature of the spliceosome has made it 
very difficult to study structurally as a whole. The heterogeneity of splicing complexes 
makes it a bad candidate for crystallography, and its multi-megadalton size puts it well 
over the upper limit for NMR. Recent advances in cryo-electron microscopy (cryo-EM) 
technology have resulted in a so-called “Resolution Revolution12” where single-particle 
cryo-EM has broken the barrier into atomic resolution with macromolecules >200 
kDa13. Due to these advances in detector technology and data processing techniques, 
there has been a recent outpouring of spliceosome structures determined via cryo-EM14–
23. These structures have shown that the RNA organization of the active site of the 
spliceosome is nearly identical to that of group II introns, which are catalytic RNAs that 
are capable of splicing in the absence of proteins24. The mechanism of splicing is also 
nearly identical in both systems in which the nucleophile for the first step is the 2′ 
hydroxyl of a conserved adenosine25 (Figure 2.1). In group II introns, the active site, 
commonly referred to as the catalytic triplex, is composed of consecutive base triples 
involving nucleotides from the catalytic triad and the two-nucleotide bulge from domain 
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V, and the junctions J2/3 and J4/5. The formation of these base triples positions the non-
bridging oxygens in the two-nucleotide bulge backbone as ligands for two Mg2+ to bind. 
Metal rescue, crosslinking and biochemistry experiments performed in yeast reveal the 
presence of base triples in the spliceosome analogous to those found in the active site 
of group II introns26. The formation of these base triples promotes catalytic metal 
binding, catalyzing both steps of splicing.  
 
 
Figure 2.1: Splicing mechanism of group II introns and the spliceosome. In both 
systems, the 2′ hydroxyl of a conserved adenosine within the intron attacks the 5′ splice 
site to form a branched intron with a unique 2′-5′ covalent bond. In the next reaction, 
the 3′ hydroxyl of the 5′ exon attacks the 3′ splice site, resulting in ligated exons and a 
free lariat intron.  
 
 The structural and functional similarities between these systems led to the 
prediction that the U2/U6 active site scaffold also contains base triples that act as a 
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platform for catalytic Mg2+ binding. However, metal ion identity and location in the 
recent cryo-EM spliceosome structures remains ambiguous, with each structure 
labelling different pockets of density as the catalytic metals. Improvements in cryo-EM 
technology have resulted the ability to push the limits of structure determination, but 
cryo-EM still has its disadvantages. Most notably, metal ion identity cannot currently 
be determined using electron microscopy. Using x-ray crystallography, however, the 
precise location and identity of metal ions can be determined from heavy metal 
anomalous scattering.  
 To understand the precise mechanism of the two transesterification reactions, 
we crystallized a U2-U6 snRNA complex. Soaking crystals with YbCl3 revealed two 
anomalous peaks ~4.3 Å apart. This distance is approximately the distance observed in 
enzymes and catalytic RNAs utilizing a two metal ion mechanism of catalysis27,28.  
 
2.3 Crystallization of the U2/U6 snRNA complex 
 Initial efforts to obtain the structure of the U2/U6 snRNA duplex were based off 
of small angle x-ray scattering (SAXS) and NMR results published by the laboratory of 
Sam Butcher29. In 2012, they published the solution structure of a truncated U2/U6 
duplex using SAXS, NMR, and molecular modeling. The U2/U6 complex contains a 
three-helix junction and forms an extended “Y” shape. This indicated that their 
truncated U2/U6 complex was an ideal candidate for structure determination using x-
ray crystallography.  
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 The U2/U6 complex used by Burke et al. 2012 was modified to contain a GAAA 
tetralooop to cap helix II and its high affinity receptor proximal to helix III (Figure 2.2) 
to facilitate intermolecular interactions. Helix II and III lengths were varied and each 
RNA was screened against the 48-condition Natrix screen from Hampton Research. 
Impressively, crystals of one of the first RNA constructs tested (U2/U6 wt) grew in 
Natrix 13 as a cluster of fine needles (Figure 2.3a) that diffracted to ~3.4 Å. To improve 
resolution and promote single crystal growth, U2/U6 wt RNA in Natrix 13 was screened 
against the additive screen from Hampton Research. The addition of 1% PEG 3350 
improved resolution to ~1.85 Å. Although the crystals grew in longer, they were still 
clustered together, obstructing the ability to loop a single crystal (Figure 2.3b). Serial 
seeding30,31 produced single crystals of the same resolution (Figure 2.3c). These crystals 
stood up to radiation damage well and one or more full datasets were able to be collected 
on a single crystal.  
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Figure 2.2: Secondary structure of the U2/U6 snRNA complex from Saccharomyces 
cerevisiae. (a) Core U2/U6 duplex sequences. Extraneous non-pairing sequences are 
omitted for clarity. (b) Truncated U2/U6 complex used for structure determination. 
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Figure 2.3: U2/U6 wt crystals and diffraction images. (a) Preliminary crystals grown 
in 1.7 M (NH4)2SO4. The resulting diffraction image shows rings instead of single spots 
because cyrstals grew in large clumps of needles. (b) Cyrstals resulting from using 1% 
PEG 3350 as an additive. Fewer needles formed from a single nucleation point resulting 
in many overlapping diffraction patterns. (c) Single crystal nucleated via seeding 
suspended in a nylon loop. The resulting single diffraction pattern extends to 1.85 Å.  
  
33 
 Performing molecular replacement using the solution structures of the U2/U6 
complex did not yield any promising results, nor did performing molecular replacement 
with smaller A-form RNA fragments as laid out by William Scott32. Therefore, U2/U6 
wt + 1% PEG 3350 crystals were soaked with YbCl3 to obtain initial phase information. 
YbCl3 is commonly used as an anomalous scatterer to experimentally determine initial 
phases in RNA crystals. It exhibits the same octahedral coordination geometry as Mg2+ 
and preferentially binds to sites containing highly coordinated magnesium ions33,34. 
YbCl3 soaks revealed two anomalous peaks ~4.3 Å apart (Figure 2.4). It is well known 
that 4 Å is the preferred distance between metals in a two-metal ion mechanism28. 
Hence, two anomalous peaks at such a distance suggests that the U2/U6 complex folds 
in a functionally relevant way to properly position the catalytic triplex to bind two Mg2+.  
 
 
Figure 2.4: Yb3+ anomalous density from U2/U6 crystals. The Yb3+ anomalous map 
(blue mesh) reveals two large peaks 4.3 Å apart. 4 Å is the preferred distance for a two-
metal mechanism28.  
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 Multiwavelength Anomalous Dispersion (MAD) was used to obtain density for 
model building. The density appeared to contain sections resembling A-form helices 
crossing over one another with clear density for base pairs (Figure 2.5). Surprisingly, 
distance between the density resembling stacked base pairs was too close to 
accommodate a proper RNA backbone. The defective nature of this density is likely due 
to reticular twinning35.  
 
 
Figure 2.5: Initial density obtained from multi-wavelength anomalous dispersion 
(MAD) of U2/U6 crystals soaked in YbCl3. The preliminary density resembles a 
crisscross pattern of nucleic acid helices.  
 
2.4 U2/U6 embedded in group II introns 
 In addition to crystallizing the free U2/U6 RNA complex, I performed 
crystallization trials of a construct containing the U2/U6 complex embedded in domain 
III of the group II intron, Oceanobacillus iheyensis (O.i.). The crystal structure of this 
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group II intron had been previously determined in 2008 by Dr. Navtej Toor33. In that 
structure, it is evident that domain III contains a stem loop that is not making any 
intramolecular contacts and is extending out from the intron, making it a good candidate 
for chimeric engineering for structure determination. I engineered a construct in which 
the U2/U6 complex is inserted into domain III of O.i. (Figure 2.6). Domain II and IV 
stem lengths were varied and constructs were screened against the 48-condition Natrix 
screen from Hampton Research.  One construct produced crystals that diffracted to ~6 
Å, but attempts to improve resolution were unsuccessful.  
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Figure 2.6: Secondary structure showing U2/U6 embedded in domain III of the 
Oceanobacillus iheyensis (O.i.)  group II intron. Domain coloring of O.i. is consistent 
with the coloring of the P.li.LSUI2 intron shown in Fig. 5.3 except that the U2/U6 
complex is shown in pink. 
 
2.5 The use of protein chaperones to assist in crystallization 
 In an effort to obtain high resolution crystals that are not twinned, we turned to 
the use of protein chaperones36,37. Even stable, conformationally homogeneous RNAs 
may have difficulty creating well-ordered crystals. This is most likely due to the fact 
that the surface of RNA molecules is composed of a regular arrangement of negatively 
charged phosphates. In the absence of well-defined intermolecular RNA-RNA tertiary 
interactions, it is likely that the RNA molecules may pack in an inconsistent way, 
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making subtly different intermolecular contacts. Crystallographers have engineered 
specific RNA-RNA38 and RNA-protein39,40 interactions into RNA constructs to 
differentiate the RNA surface landscape to facilitate more precise crystal contacts. 
 Several RNA-binding proteins have been used to aid the crystallization of RNA 
including the human spliceosomal protein U1A40 and recombinant antibody fragments 
(Fabs)41,42. U1A has been most frequently used as a crystallization module because of 
its extensive characterization40,43, high binding affinity (~20 pM)43, and relatively small 
RNA-binding sequence (10 nucleotide loop)44. We engineered the U1A binding 
sequence into the end of helix II (Figure 2.7) and bound to recombinantly expressed 
U1A. An electrophoretic mobility shift assay confirmed RNP assembly (Figure 2.8a). 
There is no observable difference between a U1A:RNA ratio of 0.5:1 and 1.5:1 
suggesting that either U1A binding becomes saturated at ~50% of RNA bound or that 
the concentration determined for U1A is incorrect. A U1A:RNA ratio of 2:1 was used 
to prepare RNP for crystallization trials and the excess, unbound U1A was removed by 
filtration. Initial crystallization trials resulted in crystals that grew in Index 7 (Hampton 
Research) and diffracted to ~2.8 Å. Unfortunately, these crystals exhibited signs of 
pseudomerohedral twinning and further attempts to eliminate twinning, as had been 
previously effective for crystals of the enzyme Dicer45, were unsuccessful.  
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Figure 2.7: U2/U6 snRNA secondary structures with U1A and MS2 coat protein 
binding sequences.  
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Figure 2.8: Representative U1A and MS2 EMSA. (a) Native PAGE showing an 
electrophoretic mobility shift of the U2/U6 complex upon binding U1A. There is no 
observable difference between a U1A:RNA ratio of 0.5:1 and 1.5:1. (b) Native PAGE 
showing an electrophoretic mobility shift of the U2/U6 complex upon binding the MS2 
coat protein. Protein:RNA ratio is calculated for the MS2 coat protein dimer. (c) Native 
PAGE showing U2/U6-MS2 RNP assembly at room temperature vs. 4oC. Each sample 
was assembled with two-fold molar excess of the MS2 coat protein and incubated at the 
indicated temperature for 24 hours.  
 
 The MS2 coat protein is another potential crystallization module. Each MS2 coat 
protein is ~14 kDa and only the dimer is capable of binding RNA. The larger size (~28 
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kDa MS2 coat protein dimer vs. 10.9 kDa U1A) and pM binding affinity to a15-nt stem 
loop46,47 make it a promising candidate as a crystallization aide. Currently, the MS2 coat 
protein is frequently used for the biochemical purification of RNA-protein complexes48 
and the detection of RNA in living cells49 because of its tight binding to the cognate 
RNA sequence. I wondered if the MS2 coat protein’s tight binding and larger size would 
make it useful as a crystallization chaperone. The U2/U6 snRNA complex was 
engineered to contain the high affinity MS2 hairpin in helix II (Figure 2.7). Interestingly, 
the protein was only found to bind RNA at 4oC. RNP formation was only observed at 
room temperature for short (< 1 hour) incubation times (Figure 2.8b).  
 
2.6 Methods 
In vitro transcription 
 U2/U6 constructs with variable helix II and III stem lengths and loop sequences 
were made via overlapping PCR to contain a HindIII restriction site at the 3′ end and 
cloned into pUC57 using the EvoRV cute site. Plasmids containing the U2/U6 sequence 
followed by a HindIII restriction site were linearized prior to in vitro transcription. Run-
off transcription was performed overnight at 37°C using 0.04 mgml-1 linearized plasmid 
in 25 mM MgCl2, 2 mM spermidine, 5 mM DTT, 40 mM Tris-HCl pH 7.5, 0.05% Triton 
X-100, 2.5 mM of each NTP, T7 RNA polymerase purified in house and thermostable 
inorganic pyrophosphatase (New England Biolabs). CaCl2 was added to a final 
concentration of 1.2 mM. The reaction mixture was treated with turbo DNase (Life 
Technologies) for 45 min followed by proteinase K (Life Technologies) for 1 hr. U2/U6 
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RNA was washed sufficiently with 10 mM MgCl2, 5 mM sodium cacodylate pH 6.5 
using an Amicon Ultra-15 centrifugal filter with a 30 kDa molecular weight cut off and 
concentrated to 10 mgml-1. For U2/U6-U1A and U2/U6-MS2 constructs, RNA was 
incubated with 2 molar equivalents of either U1A or MS2 coat protein in 10 mM MgCl2, 
5 mM sodium cacodylate pH 6.5 at room temperature for 3 hours then concentrated to 
10 mgml-1.  
Crystallization 
 Initial crystallization trials were performed using an Art Robbins crystallization 
robot to set sitting drops against the Natrix, Index, and Crystal screens from Hampton 
Research. Equal volumes of RNA (10 mgml-1) were mixed with 0.5 mM spermine and 
the precipitant solution. In the case of trays set with the additive screen, an equal volume 
of each additive was added to the RNA/spermine/precipitant mixture. Crystals were 
exchanged into solutions containing 0.5 mM spermine, 15 mM Mg(Oac)2, 50 mM 
sodium cacodylate pH 6.0, 1% PEG 3,350, saturated (NH4)2SO4 both without and with 
15 mM YbCl3 (U2/U6 alone); or 0.5 mM spermine, 100 mM NH4OAc, 20 mM MgCl2, 
50 mM HEPES pH 7.0, 6% PEG 8,000, and 32% MPD (Oi-U2U6); or 0.5 mM 
spermine, 100 mM citric acid pH 3.5, 3.6 M NaCl (U2U6-U1A).  
Seeding 
 Initial crystals were grown in sitting drops by means of vapor diffusion at 30°C 
using 10 mgml-1 RNA, 0.5 mM spermine, 15 mM Mg(Oac)2, 50 mM sodium cacodylate 
pH 6.0, 1% PEG 3,350, and 1.7 M (NH4)2SO4. Clusters of needles appeared within 16-
48 hours and were transferred to a stabilization solution containing 15 mM Mg(Oac)2, 
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50 mM sodium cacodylate pH 6.0, 1% PEG 3,350, and saturated (NH4)2SO4. Crystals 
were homogenized using ceramic Seed Beads (Hampton Research) and streaked into 
drops containing 6 mgml-1 RNA equilibrated against 15 mM Mg(Oac)2, 50 mM sodium 
cacodylate pH 6.0, 1% PEG 3,350, and 1.7 M (NH4)2SO4 at 30°C. Single needle crystals 
appeared within 16-48 hours.  
Multiwavelength Anomalous Dispersion 
 Crystals were either grown or soaked (24 hrs) in 5 mM ytterbium (III) chloride. 
The high salt concentrations in the crystallization conditions necessitated use of a higher 
ytterbium (III) chloride concentration to permeate the crystals. X-ray data sets were 
collected at NE-CAT’s 24-ID-C beamline at the Advanced Photon Source (Argonne 
National Laboratory, Argonne, Illinois). Data was processed using HKL-200050, heavy 
metal sites were identified with SHELXD51 and phasing done using Phenix52 and 
SHELXE53. RNA nucleotides were modeled using COOT54 and the RCrane plugin55. 
The phylogenetically predicted secondary structure (Figure 5.1) guided modeling into 
the electron density. Structure refinement was done using Buster56, Phenix52, DEN57, 
and Phenix.Erasser58. All software was compiled by SBGrid59. 
Electrophoretic mobility shift assays 
 U2/U6-U1A samples were prepared by incubating 10 µg RNA with 0.1-1.5 
molar equivalents of U1A in 15 µL of 10 mM MgCl2, 5 mM sodium cacodylate pH 6.5 
at 37°C for 30 min. Samples were diluted to 0.1 µgµL-1 with loading buffer and 0.75 µg 
was loaded per lane on a 5% 37.5:1 acryalmide:bisacrylamide, 4% glycerol, 0.5X TBE 
gel. U2/U6-MS2 samples were prepared by incubating 1 µg RNA with 0.25-1.5 molar 
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equivalents of MS2 coat protein in 10 mM MgCl2, 100 mM NaCl, and 50 mM HEPES 
pH 7.5 at room temperature for 1hr (Figure 2.8b), room temperature for 5 hrs or 4°C for 
32 hours. Samples were run on 5% 37.5:1 acrylamide:bisacrylamide, 4% glycerol, 0.5X 
TBE gels. All gels were run at a constant 5 watts at 4°C.  
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Chapter 3: Structural basis for the second step of group II 
intron splicing 
 
3.1 Abstract 
 The group II intron and the spliceosome share a common active site architecture 
containing multiple base triples that are essential for catalysis and splice via the same 
lariat-forming mechanism. Due to these similarities, they are thought to be 
evolutionarily related. Here we report the 3.7 Å crystal structure of a eukaryotic group 
II intron in the lariat-3′ exon form, immediately preceding the second step of splicing. 
The intact 3′ splice site is positioned in the active site adjacent to the catalytic metal ions 
and the 3′-OH nucleophile of the 5′ exon. This represents the first structure of either the 
group II intron or the spliceosome with an intact 3′ splice site. Comparisons with the 
post-catalytic structure reveal extensive rearrangements occurring within the catalytic 
triplex. As splicing progresses, the conserved linker sequences J2/3, J4/5 and J5/6 
engage in a “shuffling” action within the catalytic triad of domain V to facilitate 3′ splice 
site capture for the transition towards the second step of splicing and exon ligation. 
Mutagenesis of this triplex results in first- or second-step splicing defects consistent 
with its role in the spatiotemporal positioning of substrates within the active site during 
the splicing reaction. Therefore, we hypothesize that each stage of splicing is associated 
with a specific, unique arrangement of the catalytic triplex.  
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3.2 Introduction 
 Group II introns are self-splicing ribozymes that catalyze two transesterification 
reactions to excise themselves from nascent mRNA. In the first step of splicing, the 2′-
OH of a bulged adenosine residue is used as the nucleophile to attack the 5′ splice site. 
This is followed by a second step in which the free 3′-OH of the 5′ exon attacks the 3′ 
splice site to form ligated exons. The chemistry of this RNA splicing reaction is identical 
to that found in the splicing of nuclear introns by the spliceosome in eukaryotes. 
Recently, cryo-EM structures of the spliceosome were determined at high-resolution 
and revealed that its active site architecture is highly conserved with that of group II 
introns, with both utilizing a two-metal-ion mechanism to catalyze RNA splicing1–10. 
This structural homology suggests an evolutionary link between group II introns and 
the spliceosome.  
 Structures are available of both the group II intron and the spliceosome at 
different stages of catalysis; however, the intact 3′ splice site has not yet been visualized 
in either splicing system. In fact, no density for the 3′ exon has been seen in any of the 
spliceosome structures. The precise location of the 3′ splice site would provide insight 
into the mechanism of the second step of splicing. Here we report the 3.6 Å crystal 
structure of a eukaryotic group IIB intron from the brown algae Pylaiella littoralis 
(P.li.LSUI2) in the lariat-3′ exon form with an intact 3′ splice site docked into the 
catalytic core. This is the first structure of a group II intron immediately preceding the 
second step of splicing. The intact 3′ splice site is aligned in the active site adjacent to 
the two catalytic Mg2+ ions and the 3′-OH nucleophile of the 5′ exon. We also observe 
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conformational rearrangements within the active site in the transition from the lariat-3′ 
exon form to ligated exon product.  
 
3.3 Structure of the lariat-3′ exon intermediate 
 The structure of lariat-3′ exon intermediate in the pre-second step (pre-2S) state 
was determined at 3.6 Å resolution (Rfree = 25.4%) (Figure 3.1 and Table 3.1). The 
intact 3′ splice site was biochemically confirmed with a sequence analysis of the 
crystallized RNA (Figure 3.2). In addition, the refinement of the previous post-catalytic 
structure11 (iridium hexammine derivative) was further improved to yield an Rfree = 
25.5% (Table 3.1). The presence of iridium hexammine favors the post-catalytic state 
(Figure 3.3), whereas its absence stalls splicing in crystallo prior to the second step.  
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Figure 3.1:  Structure of the lariat-3′ exon intermediate. Inset image shows the intact 
3′ splice site positioned in close proximity to the catalytic two-metal-ion center and the 
3′-OH nucleophile of 5′ exon. The IBS3-EBS3 interactions positions serves to properly 
position the 3′ splice site. 
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Table 3.1: Data collection and refinement statistics 
  P.li.LSUI2 Pre-2S P.li.LSUI2 Post-Catalytic 
Rerefine 
Data collection    
Space group  C2221 C2221 
Cell 
dimensions   
   
    a, b, c (Å)  165.01, 256.89, 137.23 163.7, 255.4, 136.8 
  a, b, g (°)   90, 90, 90 90, 90, 90 
Resolution (Å)  150.00-3.70 (3.83-3.70) 150.0-3.68 (3.74-3.68) 
(3.74-3.68) Rsym or Rmerge  11.4 (58.6) 14.9 (>100) 
I / sI  15.1 (1.21) 6.4 (0.6) 
Completeness (%)  97.1 (92.9) 99.9 (99.9) 
Redundancy  3.5 (3.2) 6.8 (3.8) 
    
Refinement    
Resolution (Å)  50.08-3.70 (3.82-3.70) 81.83-3.68(3.77-3.68) 
No. reflections  31200 31107 
Rwork / Rfree  21.63/25.40(32.12/34.09) 20.99/25.48(36.93/42.48) 
No. atoms  13881 14107 
    RNA  13541 13479 
    Ligand/ion  104 382 
    Water  236 246 
B-factors    
    RNA  200.4 192.7 
    Ligand/ion  157.9 179.5 
    Water  172.0 159.0 
R.m.s. deviations    
    Bond lengths 
(Å) 
 0.002 0.009 
    Bond angles (°)  0.516 1.080 
* Values in parentheses are for highest-resolution shell. 
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Figure 3.2: Sequence analysis of the 3′ end of crystallized RNA from the pre-2s and 
post-catalytic states. (left) Crystallized RNA was first incubated with debranching 
enzyme to digest the 2′-5′ phosphodiester of the lariat. This allows 3′ end mapping 
without steric clashes with the reverse transcriptase and the lariat bond during primer 
extension. A poly(A) tail was added to the 3′ end using poly(A) polymerase. Primer 
extension was using an oligo dT primer and reverse transcriptase. (right) Fluorescent 
sequencing traces show an intact 3′ splice site in the absence of iridium hexammine, 
whereas the iridium hexammine-containing sample does not contain 3′ exon. This 
supports the x-ray data, which shows density for the 3′ splice site in the absence of 
iridium hexammine. 
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Figure 3.3:  Iridium hexammine stimulates the forward splicing reaction. (left) At 
a limiting magnesium concentration of 3mM, iridium hexammine strongly favors the 
post-catalytic state with no visible pre-2s state during the splicing time course. In the 
absence of iridum hexammine, the pre-2s state is easily visible during the time course. 
(right) Iridium hexammine stimulates splicing at micromolar concentrations. 
 
 In order to avoid model bias, Fo-Fc omit maps were calculated by deleting 
nucleotides spanning the 3′ splice site (Figure 3.4) for both the pre-2s and post-catalytic 
structures. This reveals density for an intact 3′ splice site in the pre-2s crystals and 
confirms that this structure represents the state directly preceding the second step. A 
comparison of both structures reveals significant differences within the catalytic domain 
V (DV), the branch site helix domain VI (DVI), and the 3′ end of the intron. Examination 
of the intron core reveals the 3′-OH of the 5′ exon poised to engage in nucleophilic 
attack at the intact 3′ splice site (Figure 3.1). The scissile phosphate junction at the 3′ 
splice site is highly distorted and kinked as predicted by Chan et al. (2012)12. This 
distortion probably aids in presenting the correct scissile phosphate to the catalytic metal 
ions for cleavage in the second step in addition to applying additional strain on this bond 
to assist cleavage. The 3′ splice site is positioned in the core via DVI and the IBS3-
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EBS3 interaction. IBS3-EBS3 consists of a single Watson-Crick pair between the first 
nucleotide of the 3′ exon (IBS3) and an internal intron base (EBS3), while domain 6 is 
covalently attached immediately upstream of the 3′ splice site. The 3′ splice site is also 
positioned by a single Watson-Crick pair between the 3′ terminal nucleotide of the 
intron and a residue from J2/3 (γ-γ′ interaction). This interaction is critical for placing 
the scissile phosphate of the 3′ splice site near the catalytic metal ions. γ-γ′ is not 
engaged in the observed pre-2s state, thus accounting for the 10 Å distance between the 
3′ splice site and the catalytic metal ions M1 and M2. The γ nucleotide from J2/3 is 
flipped 180° away from the active site and therefore cannot form the pairing with the 3′ 
terminal nucleotide (γ′) of the intron. The lack of this interaction accounts for the fact 
that the 3′ splice site is intact in this structure. This also suggests that γ-γ′ is a transient 
and dynamic contact. 
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Figure 3.4:  Density for the 3′ splice site in the lariat 3′-exon intermediate. Fo-Fc 
omit maps (contoured at 3 σ) were calculated for the region spanning the 3′ splice site 
in both the post-catalytic and pre-2s states. The cleaved 3′ end is clearly visible in the 
post-catalytic state versus the intact 3′ splice site in the pre-2s structure. 
 
 A comparison of this pre-2s structure with the post-catalytic state suggests that 
the pathway between the first and second steps of splicing consists of multiple 
conformational rearrangements that set the stage for 3′ splice site capture and cleavage 
(Figure 3.5). A comparison of the pre-2s and post-catalytic structures reveals that the 
basal stem of DVI (containing the bulged adenosine) undergoes a “compression” in the 
transition to the second step. Figure 3.6 shows a superposition of the DVI region from 
both structures. In particular, the backbone of the bulged adenosine residue is distorted 
once exon ligation is completed in the post-catalytic state. Given that the scissile 
phosphate of the 3′ splice site is not in a position to be cleaved in the pre-2s structure, 
we hypothesize that this compression of the DVI helix assists in positioning the 3′ splice 
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site into close proximity to the catalytic metals ions and the 3′-OH nucleophile of the 5′ 
exon for exon ligation.  
 
 
Figure 3.5: Model for the second step of group II intron splicing. This model 
illustrates events occurring after the first step and the exit of the 2′-5′ lariat 
phosphodiester bond from the active site. The catalytic triplex prepares for the second 
step with J2/3 residue A422 disengaging from A551. U549 replaces the position 
previously occupied by A422. EBS3-IBS3 then forms to anchor the 3′ end of the intron 
and causes A586 of J5/6 to displace U549 at the base of DV to activate the catalytic 
triplex for the second step. Finally, A420 (γ) enters its active conformation by stacking 
under A573. The formation of g-g′ draws the 3′ splice site into the active site and 
promotes proper exon ligation. 
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Figure 3.6: Superposition of DVI in the post-catalytic and pre-2s states. (a) Two 
Ir(NH3)63+ and one Mg(H2O)62+ are bound to the major groove of DVI in the post-
catalytic structure. Ir3+ anomalous maps (light blue) are contoured to 2.0σ, Mg(H2O)62+  
Fo-Fc map (green) is contoured to 3.6σ. (b) The pre-2s (orange) and post-catalytic (blue) 
DVI conformations are superimposed. This reveals conformational rearrangements at 
the basal region of the DVI stem. The backbone of the bulged adenosine residue in 
particular undergoes repositioning with less distortion in the pre-2s state.  
 
3.4 Novel catalytic triplex arrangement in the lariat-3′ exon 
intermediate 
 The catalytic triplex in group II introns consists of consecutive base triples 
involving nucleotides from the catalytic triad, the two-nucleotide bulge, and a linker 
sequence between domains II and III (J2/3). Marcia and Pyle (2012) were the first to 
discover the existence of conformational rearrangements in the catalytic triplex of the 
hydrolytic group IIC intron13. However, these rearrangements were only observed 
through growth of the crystals in an ionic condition not supporting splicing. This work 
revealed that J2/3 is disengaged from the catalytic triad in the pre-catalytic state and is 
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engaged in the active form. Prior to these structural studies, Jarrell (2000) had observed 
that mutagenesis or deletion of J2/3 resulted in strong inhibition of splicing in the aI5γ 
intron14. Therefore, the cumulative evidence suggests that the residues involved in the 
catalytic triplex are playing an essential role in the transition between the two steps of 
splicing.   
 The structure of the post-catalytic eukaryotic IIB intron revealed the first 
evidence for additional junction nucleotides (other than J2/3) participating in base 
triples within the catalytic triplex. In comparison with the IIC intron, we observed in the 
IIB intron that A422 of J2/3 disengages with A551 of the catalytic triad to form a base 
triple with U549 of J4/5 and U584 of J5/6 at the base of DV11 (Figure 3.7). Surprisingly, 
the pre-2s structure presented in the current study reveals yet another configuration of 
the catalytic triplex (Figure 3.7). In comparison with the post-catalytic structure, A586 
of J5/6 has taken the place of U549 in the base triple below DV, which promotes U549 
to form a base triple with A551 and U583 of the triad. We hypothesize that this catalytic 
triplex represents an active conformation that corresponds to the second step of splicing. 
In light of these two additional triplex configurations, it is probable that the triplex 
observed in the bacterial group IIC intron corresponds to the first step of splicing. IIC 
introns are known to engage in random hydrolytic cleavage at the 3′ end, which removes 
J5/6, domain VI and the 3′ splice site15,16. Therefore, in the absence of essential 
nucleotides required for the second step, the IIC intron becomes locked into the first 
step configuration.  
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Figure 3.7: Different configurations of the catalytic triplex. This shows the three 
known configurations of the catalytic triplex in group II introns. The configuration in 
O. iheyensis is thought to represent the configuration required for the first step.  
 
3.5 Catalytic triplex nucleotides modulate RNA splicing 
 To test the function of the junction nucleotides in the P.li.LSUI2 intron, we 
altered the sequence and length of the J2/3, J4/5 and J5/6 linkers (Figure 3.8). Mutations 
within J2/3 had significant effects upon both steps of splicing depending on the specific 
alteration.  A J2/3 ΔGA mutant resulted in a severe catalytic defect with almost no 
splicing. However, a J2/3 G241C mutant resulted in a large inhibition of the second step 
with a 4-fold greater accumulation of lariat-3′ exon intermediate compared to WT. In 
contrast, mutagenesis of the J4/5 linker largely results in an inhibition of the first step 
with the +GC mutant resulting in a 4-fold increase in unspliced, precursor RNA relative 
to WT. The J5/6 linker resulted in the most diverse effects upon splicing with the largest 
magnitude inhibition of either the first or second step with various mutations. It was 
previously seen in the aI5γ intron that mutations in the J5/6 linker result in alternative 
3′ splice site selection. This is consistent with a role for J5/6 and the catalytic triplex in 
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ensuring the fidelity of splice site selection. Taken together, the cumulative data are 
consistent with a model in which dynamic rearrangements of the catalytic triplex are 
responsible for the positioning and removal of exon substrates from the active site in 
the transition between the two steps of splicing (Figure 3.5). The catalytic triplex also 
exists in the spliceosome, however in this case, protein-mediated conformational 
rearrangements may have taken over the role played by the dynamic triplex in group II 
introns (Figure 3.9). 
 
 
Figure 3.8: Fraction of splicing components for junction mutants. Fraction of 
precursor (purple), linear intron-3′ exon with lariat-3′ exon (grey), and linear intron with 
lariat (orange) are shown for wild type and several mutations of key residues in J2/3 
(blue underline), J4/5 (wheat underline), or J5/6 (red underline). The DUG mutation of 
J5/6 was the only mutation observed to alter the preference of the first step nucleophile 
as this mutation results in a complete loss of branched product.  
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Figure 3.9: The core architecture of the spliceosome. The spliceosome structure 
contains analogous junction nucleotides to the group II intron (shown in blue and wheat, 
Figure 3.7). Cef1 (cyan), spliceosomal protein and component of the Prp19 complex, 
spans a large distance into the overall structure and makes contacts with the backbone 
of analogous J2/3 and J4/5 residues (PDB 3JB9). Mutations of 2 Cef1 residues are 
strong suppressors of second step splicing defects, indicating that this protein plays a 
significant role in communicating the fidelity of second step substrates17.  
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Figure 3.10: Sequence conservation of junction nucleotides. (a) The junction 
nucleotides of the group II intron are highly conserved, and correlate to their observed 
function in the pre-2s structure. (b) The Spliceosome junction nucleotides identified by 
either their proximity to the catalytic triad (J4/5 and J5/6 analogues) or their previous 
biochemical data (J2/3 analogue). Dashed boxes denote the junction nucleotides. Red 
numbers indicate bases identified to participate in the catalytic triplex. Nucleotide 
numbers for the group II intron and spliceosome sequences correspond to P.li.LSUI2 
and S. pombe. 
 
3.6 Supplementary Discussion: Iridium hexammine favors the post-
catalytic state 
 Previously, we solved the structure of the P.li.LSUI2 intron in the post-catalytic 
state using crystals which were soaked in iridium hexammine prior to data collection9. 
Inspection of the major groove of DVI revealed two iridium hexammine molecules and 
a magnesium hexahydrate near the proposed conformational switch known as the p-p′ 
interaction. This interaction engages after the first step of splicing to remove the newly 
formed lariat out of the active site to allow entry of the 3′ splice site, which is crucial 
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for the transition to the second step of splicing. We had postulated that the region of 
DVI surrounding the p-p′ interaction is flexible and dynamic to allow the observed 20 
Å displacement of the lariat bond out of the active site after the first step. Data was also 
collected on the native dataset in the absence of iridium hexammine. Rigid body 
refinement of the iridium hexammine derived structure into the native dataset revealed 
the presence of multiple positive and negative Fo-Fc peaks within the catalytic triplex 
of DV and at the 3′ end of the intron (not including the absence of iridium hexammine 
and minor metal ions). Further analysis showed strong density corresponding to an 
intact 3′ splice site. In contrast, the iridium hexammine derivative had density for ligated 
exons in the active site. Therefore, we hypothesized that the native dataset represents 
the lariat-3′ exon form of the intron immediately preceding the second step of splicing. 
Further evidence for this hypothesis was provided by an analysis of the 3′ end of the 
RNA present in both the native crystals and the iridium hexammine derivative. End 
mapping on this crystallized RNA was done to determine the cleavage pattern at the 3′ 
splice site (Figure 3.2). The RNA from the crystals was first treated with debranching 
enzyme to digest the 2′-5′ phosphodiester bond of the lariat. This allows primer 
extension at the 3′ end without interference from this branched linkage. A polyA tail 
was then added using polyA polymerase followed by RT-PCR and cloning. This 
confirmed the presence of an intact 3′ splice site in the native crystals and spliced, post-
catalytic intron in the iridium hexammine derivative.  
 Given that the self-splicing of group II introns is reversible, we hypothesized 
that iridium hexammine inhibits the backward reaction and favors the equilibrium 
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towards the post-catalytic-state in the crystals. This is supported by splicing reactions 
of P.li.LSUI2 in the presence or absence of iridium hexammine in a limiting Mg2+ 
concentration of 4 mM (Figure 3.3). Conditions lacking iridium hexammine are unable 
to support splicing. In contrast, supplementation with iridium hexammine at 
concentrations as low as 50 µM (~80-fold lower than [Mg2+]) is able to promote 
splicing. The low concentration of iridium hexammine required to initiate splicing 
suggests that it may be playing a more complex role beyond simple charge 
neutralization of the phosphate backbone. In addition, analysis of the splicing products 
reveals that there is no visible lariat-3′ exon intermediate (representing the pre-second 
step state) for reactions containing iridium hexammine. This is highly unusual in that 
most group II introns form a significant amount of this intermediate during time courses 
of in vitro splicing reactions. This is in contrast to the splicing reaction at 5.4 mM Mg2+ 
(in the absence of iridium hexammine), which results in the significant accumulation of 
lariat-3′ exon intermediate. The fact that this intermediate is not visible in the presence 
of iridium hexammine suggests that this metal complex has a stimulatory effect on the 
second step to favor the post-catalytic state.  
 
3.7 Methods 
Crystallization of P.li.LSUI2 RNA 
 The crystallization construct was in vitro transcribed and purified as previously 
described11. The same conditions were used to grow the rod-like cyrstals, which were 
then gradually exchanged into 21% MPD, 100 mM magnesium acetate tetrahydrate, 50 
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mM MES monohydrate (pH 5.6), 0.5 mM spermine, and 100 mM NaCl; followed by 
flash freezing in liquid nitrogen. It is important to note that no iridium hexammine was 
present at any step of crystallization or crystal freezing.  
Structure Determination 
 X-ray data sets were collected at NE-CAT’s 24-ID-C beamline at the Advanced 
Photon Source (Argonne National Laboratory, Argonne, Illinois). Data was processed 
using HKL-200018. The post-catalytic structure of P.li.LSUI2 (PDBID 4R0D) was used 
as a search model for molecular replacement using PHENIX19. The last 10 and 5 
nucleotides of the intron and 5′ exon, respectively, were deleted to avoid model bias. 
RNA nucleotides were modeled using COOT20 and the RCrane plugin21. Structure 
refinement was done using Buster22, PHENIX19, DEN23, and Phenix.Erasser24. SBGrid 
compiled all the software used25. Sequence logos were prepared using WebLogos26. 
In vitro self-splicing assays 
 Constructs used for in vitro self-splicing assays were modifications of the wt 
P.li.LSUI2 sequence with the DIV ORF removed and a 250 nt 5′ exon and 75 nt 3′ exon. 
This construct was cloned into pUC57 using the EcoRV cut site. Plasmids were 
linearized using BamHI to be used as templates for in vitro transcription. Radiolabeled 
transcripts were prepared using T7 RNA polymerase, 5 mM MgCl2, 40 mM Tris-HCl 
pH 7.5, 0.05% Triton X-100, 10 µCi [α-32P]UTP (3,000 Ci mmol-1), 0.5 mM UTP, and 
1 mM other NTPs. RNA was transcribed for 1 hr at 37°C then precursor RNA was gel 
purified on a denaturing 4% (19:1), 8 M urea, 1X TBE gel. To refold, radiolabeled 
precursor RNA and an internal control RNA in 40 mM Tris-HCl pH 7.5 was heated at 
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90°C for 1 min followed by incubation in 40 mM Tris-HCl H 7.5, 10 mM MgCl2 for 15 
min. To initiate self-splicing, RNA was mixed with an equal volume of 2X splicing 
buffer (2 M NH4Cl, 40 mM Tris-HCl pH 7.5). Reactions were quenched by mixing with 
an equal volume of 80% formamide, 100 mM EDTA. Splicing products were resolved 
using denaturing 4% (19:1), 8 M urea, 1X TBE gels. All splicing assays were done in 
triplicate.  
Quantitation of self-splicing products 
 Splicing gels were exposed to storage phosphor screens and splicing products 
were quantitated using Quantity One 1-D Analysis Software. Unequal loading was 
accounted for by normalizing to an internal control RNA. Band intensity was 
determined by dividing the background-subtracted intensity of each band by the number 
of Us in the RNA sequence corresponding to the band. All band intensities were then 
normalized to an unspliced control to give fractional values of input RNA.  
3′ end mapping 
 Native and Ir(NH3)63+-soaked crystals were rinsed with excess crystallization 
solution to remove uncrystallized RNA then dissolved in 50 mM HEPES pH 7, 100 mM 
NaCl, 1 mM DTT, 0.1 µM Dbr1 and incubated at 37°C for 30 min to hydrolyze the lariat 
bond. RNA was phenol-chloroform extracted, ethanol precipitated and resuspended in 
nuclease free water. 1 µg debranched RNA was incubated with 1 mM ATP and 5 units 
of E. coli poly(A) polymerase from NEB at 37°C for 30 min to add a poly (A) tail to the 
RNA. The RNA was phenol-chloroform extracted, ethanol precipitated and resuspended 
in nuclease free water. 200 ng oligo(dT)18 and 1 µL 10 mM dNTP mix were added to 
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the RNA and the volume was brought to 13 µL with nuclease free water. To anneal the 
primer, the mixture was heated at 65°C for 5 min and incubated on ice for 1 min. The 
RNA was reverse transcribed at 50°C for 30 min using 200 units SuperScriptTM III RT, 
1X first-strand buffer, and 5 mM DTT in a final volume of 20 µL, and the RT was 
inactivated by heating at 70°C for 15 min. 2 µL of cDNA was used as a template for 
PCR using oligo(dT)18 as a reverse primer and a forward primer that anneals within the 
intron. PCR products containing a short poly (A) tail were gel extracted, cloned into 
pUC57 using the EcoRV cut site, and transformed into E. coli to sequence single 
colonies.  
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Chapter 4: A kinetic and thermodynamic analysis of domain 
VI dynamics in the group II intron P.li.LSUI2 
 
4.1 Introduction 
 RNA has evolved to fold into many complex tertiary structures to carry out a 
range of functions varying from peptide bond formation to cleavage of phosphodiester 
bonds. In order to fold into such compact shapes, distant regions in the primary sequence 
come together to form long-range tertiary interactions. Among the most common 
tertiary contacts found in highly structured RNAs is the tetraloop-tetraloop receptor 
(TL-TLR) interaction. In this interaction, a 4-nucleotide loop (tetraloop) folds into a 
conserved shape and binds to a dsRNA receptor helix. Natural tetraloop sequences have 
been found to fall into unique classes with distinct folds. The three most common 
tetraloop classes are UNCG, CUUG and GNRA, where N is any nucleotide and R is a 
purine1. These are likely the most common because of their higher stability due to the 
base-pairing between nucleotides 1 and 4, base stacking, and 2′-OH hydrogen bonding2. 
Among rRNAs, the UNCG and GRNA tetraloops account for >70% of all tetraloops3. 
The UNCG tetraloop forms a particularly stable structure, but is unlikely to form 
interactions with RNA duplexes4. Conversely, GNRA tetraloops are commonly found 
binding to dsRNA receptors to stabilize highly ordered RNAs5,6.  
 GNRA tetraloops have been found to bind to at least three receptor motifs: 11-
nt, IC3, and minor groove7. The 11-nt receptor was first discovered in the Tetrahymena 
group I intron, and because of the very high affinity between this receptor and the 
GAAA tetraloop, this TL-TLR has been used since as a tool to facilitate intermolecular 
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self-assembly in crystal packing and RNA tectonics8–12. It consists of a 5-nt internal 
loop with two consecutive adenosines forming an adenosine platform13 (Figure 4.1b). 
The IC3 receptor, named after its origin in group IC3 introns, is only slightly different 
from the 11-nt receptor and binds GNRA tetraloops more promiscuously and with a 
lower affinity14,15. The minor groove receptor is the simplest of the three as it only 
consists of the minor groove surface of two adjacent base pairs. In this interaction, the 
third and fourth tetraloop nucleotides form two base triples with the receptor base pairs. 
The simplicity of this interaction has likely contributed to its abundance in structured 
RNAs, with >60% of loop-helix interactions from x-ray crystal structures falling into 
this class7.  
 TL-TLR affinities can vary substantially, depending on the sequences involved. 
The trans-splicing group I intron has been used to study relative strengths of different 
TL-TLR sequences by equating the L2-P8 TL-TLR stability with group I intron catalytic 
efficiency6,16. These results showed variations of the L2-P8 TL-TLR that result in 
kcat/Km values spanning three orders of magnitude. So far, most TL-TLR studies have 
centered around the classical GAAA/11-nt receptor interaction. The incredibly high 
stability of this interaction makes it an excellent candidate for engineering self-
assembling modular RNAs. However, not all naturally occurring TL-TLRs are very 
stable. For instance, the group IIB intron from the brown algae Pylaiella litoralis 
(P.li.LSUI2) contains one GAAA/11-nt receptor interaction (z-z′) and four weaker TL-
TLR interactions17. Highly structured RNAs have evolved to contain weak interactions 
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for two possible reasons: 1) the interaction is not necessary for function or 2) the 
interaction is dynamic.  
 The recent crystal structure of P.li.LSUI2 in the post-catalytic lariat 
conformation was the first structure of a group II intron that showed domain VI (DVI)17. 
This domain is crucial to lariat formation as it contains the bulged adenosine that acts 
as the nucleophile in the first step of splicing. This structure revealed that the two arms 
of DII coaxially stack and form two TL-TLR interactions with DVI, p-p′ and h-h′. The 
p-p′ interaction, discovered from this crystal structure, is of particular interest because 
the receptor is directly adjacent to the bulged adenosine. Group II introns use the same 
active site for both steps of splicing18, so the bulged adenosine must be positioned in the 
active site for the first step then displaced prior to the second step to allow room for 
second step reactants. Therefore, it was surprising to see a TL-TLR interaction so close 
to the bulged adenosine. The h-h′ interaction had previously been discovered from 
DEPC modification interference analysis of the ai5g group II intron, and it was proposed 
that h-h′ forms after the first step of splicing 19. However, a low resolution pre-catalytic 
crystal structure of the P.li.LSUI2 intron shows that h-h′ is engaged prior to the first 
step17. To probe the possible dynamic nature of the p-p′ and h-h′ interactions, we 
created a screen of these TL-TLRs with varied stability and performed kinetic studies. 
These studies show that the p-p′ interaction in P.li.LSUI2 has evolved to be of moderate 
stability in order to be dynamic and facilitate both steps of splicing. Though catalysis is 
less dependent on the strength of h-h′, with <4 kcal/mol adjustments exhibiting only 
minor affects, ablating this interaction causes a significant second step defect.  
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4.2 Use of P4-P6 to determine relative binding affinities 
 In order to knowingly vary the stabilities of the p-p′ and h-h′ TL-TLRs, we first 
had to determine which TL-TLR combinations would give a range of DDGº′ relative to 
the P.li.LSUI2 wt sequences. We chose to use the P4-P6 folding assay established by 
Silverman & Cech in 1999 to screen TL-TLR combinations for varied stability20. The 
assay was developed to investigate the thermodynamic and cooperative contribution of 
specific hydrogen bonds to folding of the Tetrahymena group I intron P4-P6 domain 
and has since been used to study the specificity of RNA-RNA helix recognition21,22. In 
this assay, modified P4-P6 constructs are run on non-denaturing polyacrylamide gels at 
various [MgCl2]. Their free energy of folding (DGº′) can then be determined from Hill 
fits of relative electrophoretic mobility vs. [MgCl2]. Figure 4.1a-b shows the P4-P6 
constructs used in this assay. Five different tetraloop sequences were tested against 4 
receptor motifs, resulting in a range of electrophoretic mobilities at different [MgCl2] 
(Figure 4.1c). 
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Figure 4.1: P4-P6 folding assay and TL-TLR modifications. (a) Secondary structures 
of P4-P6 constructs used in the folding assay. The modified regions are highlighted in 
green (tetraloop) and purple (tetraloop-receptor). The construct shown on the right has 
been modified such that the J5/5a hinge sequence forms WC base-pairs, precluding 
tetraloop-receptor docking at any magnesium concentration (Silverman and Cech, 
1999). (b) Tetraloop (top) and receptor (bottom) modifications tested in the assay. (c) 
Representative non-denaturing gels of a subset of P4-P6 modifications. J5/5a base-
pairing locks the RNA in a rod-like shape, retarding migration on a polyacrylamide gel. 
TL-TLR modified P4-P6 constructs fold in a [Mg2+]-dependent manner, which is visible 
by increased mobility at higher [Mg2+].  
 
 Plots of electrophoretic mobility relative to an unfolded control (J5/5a-bp) vs. 
[Mg2+] demonstrate the variable magnesium-dependencies ([Mg1/2]) and cooperativities 
(n) of the different constructs (Figure 4.2 and Table 4.1).  Interestingly, the wt P4-P6 
construct (GAAA/11-nt motif) shows the highest cooperativity of folding (n). Hill 
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coefficients are up to 4-fold lower for TL-TLR modifications, though cooperativity does 
not appear to be correlated with the relative thermodynamic stability. 
  
 
Figure 4.2: Plots of relative electrophoretic mobility of P4-P6 TL-TLR variants vs. 
magnesium concentration. Electrophoretic mobilities of P4-P6 constructs containing 
a GAAA, GCAA, GUAA, GUGA, or GAGA tetraloop and a (a) p′ receptor (b) tandem 
GC receptor (c) 11-nt receptor or (d) CU switch receptor (shown in Figure 4.1b) on non-
denaturing gels were measured relative to the unfolded J5/5a-bp control and plotted 
against [Mg2+]. The fit values of the Hill equation (see Methods), [Mg2+]1/2 and Hill 
coefficient n, are listed for each construct.  
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Table 4.1: Relative thermodynamic stability (DDGº′) of P4-P6 TL-TLR 
modifications† 
tetraloop/receptor 
sequence 
[Mg2+]1/2 
(mM) 
Hill 
coeffiecient, 
n 
DDGº′ 
(kcal/mol) 
p-p′ 
DDGº′ 
(kcal/mol) 
h-h′ 
GUAA/p'  16.187 2.481 1.708 2.070 
GAAA/CU switch a, b 6.048 3.344 1.160 1.523 
GUAA/11-nt motif b 37.715 1.375 0.529 0.891 
GAAA/p'  14.493 1.652 0.174 0.536 
GUGA/p'  17.108 1.464 0.014 0.376 
GCAA/p'  20.958 1.359 (0) 0.363 
GAAA/tandem GC a, b 10.328 1.553 -0.313 0.050 
GAGA/tandem GC b 15.799 1.284 -0.363 (0) 
GAGA/CU switch b 11.035 1.424 -0.440 -0.077 
GUGA/11-nt motif b 11.625 1.319 -0.553 -0.190 
GCAA/tandem GC a 6.407 1.585 -0.733 -0.370 
GUGA/CU switch a, b 5.272 1.620 -0.888 -0.525 
GUGA/tandem GC a, b 6.210 1.414 -0.956 -0.593 
GUAA/tandem GC a, b 4.822 1.554 -1.040 -0.677 
GCAA/CU switch a 5.400 1.437 -1.054 -0.691 
GAGA/11-nt motif b 3.222 1.913 -1.168 -0.805 
GUAA/CU switch a, b 3.326 1.589 -1.370 -1.007 
GAAA/11-nt motif b 0.616 5.044 -4.050 -3.687 
† DDGº′ are shown relative to the P.li.LSUI2 wt (shown in bold) p-p′ interaction 
(GCAA/p′) or h-h′ interaction (GAGA/tandem GC). 
a TL-TLR combinations used in P.li.LSUI2 p-p′ constructs. 
b TL-TLR combinations used in P.li.LSUI2 h-h′ constructs. 
 
 
4.3 Splicing sensitivity to [Mg2+] and temperature 
 Though previous studies of the P4-P6 GAAA/11-nt receptor examined the 
thermodynamic and kinetic contributions of this interaction, our goal was to investigate 
the kinetics of group II intron splicing, not folding. Therefore, we verified that the 
ribozyme was fully folded via native-PAGE prior to the initiation of splicing (Figures 
4.3 and 4.4). Because we also know that there are no large-scale conformation changes 
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between the initial and final stages of splicing, and the construct used in this assay 
contains very short exons (18 and 5 nt), we expect that fully folded unspliced and spliced 
RNAs will migrate the same on a non-denaturing gel. A fraction of the RNA molecules 
fold to a compact shape as they are transcribed, but the presence of multiple bands 
running at a retarded mobility (Figure 4.3, lane 1) indicates that a small population of 
RNA molecules is stuck in partially unfolded intermediates. Increased salt and 
temperature initiates splicing and folding of partially unfolded intermediates (lane2). 
Refolding the intron in the presence of magnesium results in compact bands with high 
mobility (lanes 5 and 6). Figure 4.4 (first lane) verifies that precursor RNA does not 
splice under refolding conditions. 
  
 
Figure 4.3: Native-PAGE of P.li.LSUI2 intron folded under different conditions. 
Intron RNA was either taken immediately after 3-hr transcription (lane 1), after splicing 
the transcription (lane2), or after gel extraction and refolding (lanes 3-6) prior to running 
on a non-denaturing PAGE. To prepare spliced sample, an equal volume of 20 mM 
MgCl2, 2 M NH4Cl, 80 mM Tris pH 7.5 was added to the transcription and incubated at 
45°C for 30 min. Refolding protocol a: RNA in TE was heated at 95°C for 2 min then 
placed at room temperature for 15 min. Refolding protocol b: 4V RNA in 40 mM Tris 
pH 7.5 was heated at 95°C for 1 min then mixed with 1V 5X refolding buffer (50 mM 
MgCl2, 40 mM Tris pH 7.5) and incubated at 42°C for 15 min. Samples were run on a 
5% 37.5:1 acrylamide:bisacrylamide, 4% glycerol, 0.5X TBM gel at 4°C at 6W.  
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 Group II introns have been shown to require much higher salt concentrations 
and temperature to splice in vitro compared to in vivo23. When splicing in vivo, the intron 
encoded protein (IEP), binds to the ribozyme to assist in folding and therefore promote 
catalytic activity. When splicing in vitro, however, the RNA requires a higher 
concentration of both monovalent and divalent cations to bring highly negatively 
charged phosphate backbones in close proximity in order to properly fold 3D RNA 
structures. Increased temperature can also overcome the splicing deficiency in the 
absence of the IEP due to increased kinetic energy, though this usually requires higher 
salt concentrations to counteract increased thermal motion (Figure 4.4).  
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Figure 4.4: Representative denaturing gel demonstrating effects of [Mg2+] and 
temperature variations on self-splicing products. Gel extracted precursor intron 
(P.li.LSUI2 GAAA/11-nt receptor h-h′ modification) was refolded in the presence of 
10 mM MgCl2 (left lane) and incubated in splicing buffer containing 1 mM NH4Cl, 40 
mM Tris-HCl pH 7.5 and 1, 2, 5 or 10 mM MgCl2 at 30, 37, or 45°C for 1 hour. Splicing 
reactions were ethanol precipitated, resuspended in 50% TE, 50% formamide, and ran 
on a 6% 29:1 acrylamide:bisacrylamide, 7 M urea PAGE. 
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4.4 Kinetic analysis of p-p′ and h-h′ variations 
 It was previously shown that eliminating either the p-p′ or the h-h′ interaction 
in the P.li.LSUI2 intron by mutating the tetraloop to an inert UUCG results in an 
accumulation of intermediate lariat-3′ exon, and eliminating p-p′ and h-h′ 
simultaneously almost completely blocks exon ligation17. Interestingly, disrupting p-p′ 
or h-h′ increases the rate of the first step of splicing ~2-fold (Table 4.2). A similar result 
was observed when h-h′ was disrupted in the ai5g intron19. These results imply that both 
TL-TLR interactions are necessary for exon ligation, but their formation at least to some 
extent inhibits branching. In the P.li.LSUI2 lariat crystal structure, p-p′ is engaged and 
the bulged adenosine is ~20 Å away from the active site. It was hypothesized that p-p′ 
is disengaged for the first step of splicing, allowing the base of DVI and the bulged 
adenosine the flexibility to be positioned in the active site. After branch formation, p-p′ 
can engage to pull the bulged adenosine and the 5′ end of the intron ~20 Å out of the 
active site.  
  
Table 4.2: First step rate constants for p-p′ and h-h′ 
knock outs† 
Construct  Kslow (min-1) Kfast (min-1) Plateau 
wt  0.030 0.53 0.69 
Dp  0.036 0.92 0.65 
Dh′  0.011 1.2 0.47 
DpDh′  0.014 0.42 0.33 
† Knock outs were created by mutating the indicated 
tetraloop sequence to UUCG. 
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 In order to test this proposed splicing transition, two screens were made in which 
the p-p′ (P.li.LSUI2-p) or h-h′ (P.li.LSUI2-h) interactions were mutated to different 
TL-TLR combinations of varied strength (Table 4.1a,b). The architecture of the 
P.li.LSUI2 intron somewhat limited the possible receptor mutations that could be made. 
For instance, the distance of the bugled adenosine adenosine from the catalytic triad in 
DV has been shown to be very important, with the ideal architecture consisting of a 3-
nt linker between domains V and VI and a 4-bp stem at the base of DVI24. Because of 
the location of p′ at the base of DVI and its proximity to the bulged adenosine (Figure 
4.5), it was decided that only minor groove receptor variations would be used for p′ 
(tandem GC and CU switch). In contrast, the location of h (DIIa) is more tolerable to 
insertions because it extends out from the core of the intron (Figure 4.5a,b), so h was 
changed to the 11-nt and CU switch receptors. Additionally, because P4-P6 constructs 
containing the p′ receptor have such high [Mg2+]1/2 and therefor incomplete 
electrophoretic mobility curves, accurate DGº′ values cannot be determined for these 
constructs and p′ receptor constructs have been omitted from the P.li.LSUI2-p screen.  
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Figure 4.5: TL-TLR modifications in P.li.LSUI2. (a) Secondary structure of the 
P.li.LSUI2 intron. The sequence shown was used for crystallization and contains 
modifications from the wt sequence in DII and DIV. (b) Crystal structure of P.li.LSUI2 
(4R0D). DII and DVI are highlighted with a surface rendering. DII is shown in blue and 
DVI in magenta. (c) DII and DVI sequences used for screening varied p-p′ and h-h′ 
strengths in P.li.LSUI2.  
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 Not surprisingly, second step catalysis appears to be correlated with p-p′ 
stability. As p-p′ stability is decreased by ~2 kcal/mol, flariat decreases by ~32% (Figure 
4.6b) and flariat-3′ exon increases by ~28 % (Figure 4.6a). Because decreasing the strength 
of p-p′ inhibits second step catalysis, the first step equilibrium is perturbed, which 
results in an increased fraction of precursor (Figure 4.6c). Although P.li.LSUI2-p 
constructs predominantly splices via the branching pathway, the hydrolytic pathway is 
used to a small extent, especially when p-p′ is destabilized (Figure 4.6d). These 
observations are recorded at equilibrium, however, and do not provide any insight into 
the rate of splicing.  
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Figure 4.6: Scatter plots showing fraction of splicing reactants and products vs. 
DDGº′ for P.li.LSUI2-p constructs. P.li.LSUI2-p constructs were made by modifying 
the p-p′ sequences to those indicated in Table 4.1a. The constructs were spliced for 3 
hrs and run on a denaturing gel to quantify the fraction of (a) lariat-3′ exon, (b) lariat, 
(c) precursor (unspliced intron), and (d) linear intron, which were plotted against the 
DDGº′ values listed in Table 4.1. Solid horizontal lines indicate wt values and dashed 
horizontal lines indicate Dp values.  
 
 To investigate the effect the strength of p-p′ has on the rates of both steps of 
splicing, we performed kinetic studies on the pool of P.li.LSUI2-p constructs. The rate 
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of depletion of unspliced RNA was used to monitor the first step, and the rate of lariat 
+ linear intron accumulation was used to monitor the second step (Figure 4.7). Both 
steps of P.li.LSUI2 wt splicing are best fit as biphasic kinetic reactions. This is most 
likely due to the presence of two populations of the intron in solution that splice at 
different rates (Kslow and Kfast). However, when spliced under the same conditions as the 
equilibrium study (Figure 4.6), about 2/3 of P.li.LSUI2-p constructs exhibit monophasic 
kinetics where the rate is on the same order of magnitude as the wt-Kslow. Increasing the 
[MgCl2] to 5 mM reintroduces the fast-splicing population, making the splicing kinetics 
biphasic and more easily comparable within the P.li.LSUI2-p screen.  
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Figure 4.7: Representative time-course for self-splicing of P.li.LSUI2 and the 
kinetic analysis. (a) Time-course for self-splicing of P.li.LSUI2 wt splicing in 5 mM 
MgCl2, 1 M NH4Cl, and 40 mM Tris pH 7.5 at 30°C. (b) Plot of 1 - fPrecursor vs. time 
(min). (c) Plot of fLariat + fLinear Intron vs. time (min).  
 
 The rates of the slower splicing population show an inverse correlation with p-
p′ DDGº′ (Figure 4.8a), though the fit is very poor indicating that it is unlikely Kslow 
follows a trend. The faster splicing population exhibits no change in rate as p-p′ stability 
is perturbed (Figure 4.8b). These results contrast the effect on Kfast when the p-p′ 
interaction is eliminated by mutating the TL to UUCG (Table 4.2). However, this 
increased Kfast for the first step is observed at 1 mM MgCl2 but not 5 mM MgCl2 (data 
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not shown), suggesting that the higher [MgCl2] is able to compensate for ribozyme 
instability and conceal the effect p-p′ has on the rate of the first step. 
 The amplitude represents the percentage of the RNA population contributing to 
each rate. Examination of the first step of splicing shows no change in population 
distribution, however examination of the second step of splicing shows a significant 
decrease in the fast splicing population (Figure 4.8c,d). This indicates that the slower 
splicing population is independent of p-p′ formation.  
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Figure 4.8: Scatter plots showing splicing rates and amplitudes vs. DDGº′ for 
P.li.LSUI2-p constructs. (a) Kslow vs. DDGº′ for 1st step (purple) and 2nd step (green). 
(b) Kfast vs. DDGº′ for 1st step (red) and 2nd step (blue). (c) Amplitude of 1st step Kslow 
(purple) and Kfast (red). The plateau of precursor depletion is shown in grey. (d) 
Amplitude of 2nd step Kslow (green) and Kfast (blue). The plateau of lariat and linear intron 
accumulation is shown in grey. 
 
 Altogether, this supports the current model that p-p′ is disengaged for the first 
step and engages prior to the second step to remove the bulged adenosine from the active 
site. Constructs containing a more stable p-p′ interaction efficiently engage after the 
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first step of splicing to sequester the bulged adenosine and allow exon ligation. As 
expected, P.li.LSUI2 splices via hydrolysis less frequently with p-p′ destabilization 
because p-p′ is more frequently disengaged, allowing the first step nucleophile access 
to the active site where branching then takes place.  
 The P.li.LSUI2-h screen shows similar trends as the P.li.LSUI2-p screen for 
flariat-3′ exon and flinear intron (Figure 4.9a,d), however h-h′ DDGº′ variability induces smaller 
effects on splicing products and the data does not fit a linear trend as well. In fact, the 
constructs capable of forming the most lariat have DDGº′ that are clustered between -1 
and 0 kcal/mol (Figure 4.9b), indicating that the wt h-h′ sequence is among the best 
sequences for catalysis, and mutations that either increase or decrease stability are less 
efficient. h-h′ seems to have evolved from a “Goldilocks” scenario in which both 
weaker and tighter TL-TLR strengths are less efficient. This can also be observed in the 
Kfast amplitudes and rates for the second step of splicing (Figure 4.10b,d).  
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Figure 4.9: Scatter plots showing fraction of splicing reactants and products vs. 
DDGº′ for P.li.LSUI2-h constructs. P.li.LSUI2-h constructs were made by modifying 
the h-h′ sequences to those indicated in Table 4.1b. The constructs were spliced for 3 
hrs and run on a denaturing gel to quantify the fraction of (a) lariat-3′ exon, (b) lariat, 
(e) precursor (unspliced intron), and (f) linear intron, which were plotted against the 
DDGº′ values listed in Table 4.1. (c) and (d) show the same data as (a) and (b) except 
without the outliers highlighted in (a) and (b). Solid horizontal lines indicate wt values 
and dashed horizontal lines indicate Dh values. 
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Figure 4.10: Scatter plots showing splicing rates and amplitudes vs. DDGº′ for 
P.li.LSUI2-h constructs. (a) Kslow vs. DDGº′ for 1st step (purple) and 2nd step (green). 
(b) Kfast vs. DDGº′ for 1st step (red) and 2nd step (blue). (c) Amplitude of 1st step Kslow 
(purple) and Kfast (red). The plateau of precursor depletion is shown in grey. (d) 
Amplitude of 2nd step Kslow (green) and Kfast (blue). The plateau of lariat and linear intron 
accumulation is shown in grey. 
 
4.5 Domain VI is dynamic 
Group IIC introns primarily splice via hydrolysis in vitro to form linear intron, nullifying 
the role of DVI in the first step25. However, recent work with the Oceanobacillus 
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iheyensis (O.i.) IIC intron has shown that replacing DIc and DVI of this intron with their 
counterparts from the Azotobacter vinelandii (A.v.) intron I2 results in in vitro lariat 
formation26. Crystal structures of this chimeric intron lariat, Oc19, exhibit different DVI 
conformations dependent on the presence of an unreactive 5′ exon27. The authors 
suggest that the bulged adenosine exists as a 1-nt bulge for the first step, and a 2-nt 
bulge for the second step of splicing. It had been originally proposed that the purine rich 
strand of DVI could pair with different opposite-strand pyrimidines to accommodate p-
p′ conformation changes throughout splicing, though only the 1-nt bulge conformation 
was observed in the P.li.LSUI2 crystal structure17.  
 To test whether P.li.LSUI2 exhibits similar DVI bulge dependencies, residues 
were mutated to stabilize either the 1-nt or 2-nt bulge conformations (Figure 4.11a). 
Construct G592C:C613G, which favors the formation of a 1-nt bulge, undergoes branch 
formation but cannot ligate exons even when incubated for two hours (Figure 4.11b). In 
comparison, wt intron splicing is nearly complete after only two minutes. These results 
are in contrast with those observed for the 1-nt bulge Oc19 chimera which forms wt 
amounts of lariat but does not properly ligate exons. Construct G591C:C613G, which 
favors the formation of a 2-nt bulge, does not splice at all via the branching pathway, 
but instead forms a very small amount of linear product (Figure 4.11b). In contrast, the 
analogous Oc19 construct primarily splices via hydrolysis but is still capable of lariat 
formation and forms ligated exons at the same rate as wt. Therefore, P.li.LSUI2 does 
not exhibit similar DVI bulge dependencies. This is most likely due to the fact that the 
P.li.LSUI2 intron is more evolved than either the O.i. or A.v. introns and the p-p′ and h-
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h′ interactions have evolved to perform the same role as strand slippage in less evolved 
IIC introns.  
 
 
Figure 4.11: Time-course for self-splicing of DVI bulge constructs. (a) Equilibrium 
favored secondary structures of DVI mutants. (b) Time-course for self-splicing of 
constructs in (a).  
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4.6 Evolutionary constraints of TL-TLR interactions 
 P.li.LSUI2 is a chloroplast-like mitochondrial group IIB intron. The introns in 
this class contain highly conserved long-range tertiary interactions to properly fold the 
ribozyme28. A closer look at the frequency of p-p′ and h-h′ motifs reveals a preference 
for both interactions (Table 4.3). The most frequent tetraloops found in both interactions 
are GCAA and GUYA. In ~66% of the constructs in this class, the p′ receptor is tandem 
GC base pairs (CC:GG). The most frequently observed h receptor sequence is the 
GCC:GGC helix, found in ~47% of the constructs, with the CC:GG helix being the next 
most frequent motif in ~33% of constructs. The h sequence was determined by the first 
two nucleotides of the DIIa stem (Figure 4.5a). Interestingly, the CC:GG motif is found 
within the GCC:GGC motif and is shifted one base pair into the stem. It is likely that in 
the constructs containing a GCC:GGC receptor helix, the receptor is the tandem GC 
motif located one base pair in from the beginning of the stem. Assuming this to be the 
case, the thermodynamic stabilities of these most common TL-TLR combinations span 
~0.3 kcal/mol (Table 4.1). This is a very narrow range compared to the ~2.5-5 kcal/mol 
tested in the P.li.LSUI2-p and -h screens.  
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Table 4.3: Sequences of p-p′ and h-h′ in group IIB introns 
receptor 
helix* p tetraloop** h′ tetraloop** 
 GCAA GUYA GVGA Other GCAA GUYA GVGA Other 
CC:GG 22 21 3 1 5 16 1 2 
GCC:GGC 0 0 0 0 11 19 4 1 
UC:GA 0 1 3 1 0 2 0 0 
CU:AG 2 5 0 2 0 1 2 0 
Other 2 1 0 1 0 0 0 0 
* Receptor nucleotides are shown in bold. The p′ receptor was determined to be the 
two base pairs adjacent to the bulged adenosine. The h receptor was determined to 
be the first two base pairs of the DIIa stem.  
** Y represents pyrimidines, V represents any base except U 
 
4.7 Methods 
Preparation of RNA 
 P4-P6 and P.li.LSUI2 derivatives were cloned into pUC57. To prepare templates 
for transcription, P4-P6 sequences were amplified using PCR and P.li.LSUI2 plasmid 
derivatives were linearized with BamHI. Radiolabeled transcripts were prepared using 
T7 RNA polymerase, 25 mM MgCl2, 40 mM Tris-HCl pH 7.5, 0.05% Triton X-100, 10 
µCi [α-32P]UTP (3,000 Ci mmol-1), 0.5 mM UTP, and 1 mM other NTPs. RNA was 
transcribed for 1 hr at 37°C then gel purified on a denaturing 4% (19:1), 8 M urea, 1X 
TBE gel.  
P4-P6 folding assay 
 P4-P6 folding assays were performed as previously described20 with the 
following changes. Samples were heated at 55°C for 7 min then placed at 37°C for 15 
min in 1X TB (89 mM Tris, 89 mM boric acid, pH ~8.5) with the desired concentration 
of MgCl2. Nondenaturing 8% (29:1), 1X TB gels were prepared with MgCl2 at the 
desired final concentration. Gels were run in the same buffer on a Hoeffer SE 600 gel 
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apparatus at 15 W at 37°C, dried, and exposed to a storage phosphor screen. Igor Pro 
software was used to analyze the results. Plots of relative electrophoretic mobility vs. 
[Mg2+] were fit to a Hill equation: 
𝑦 = (base + max − base )/(1 + Mg12 3/1Mg 4) 
The Hill coefficient (n) and the concetration of Mg2+ needed to fold half of the molecules 
([Mg2+]1/2 were then used to calculate DG°′: ∆G°' = 𝑛RTln Mg12 3/1 
DDG°′ values were obtained by subtracting the DG°′ of the wt from the DG°′ of the 
mutant: ∆∆G°'	=	∆G°'(mutant) − ∆G°'(wt) 
In vitro self-splicing assays 
 Constructs used for in vitro self-splicing assays were modifications of the wt 
P.li.LSUI2 sequence with the DIV ORF removed and a 250 nt 5′ exon and 75 nt 3′ exon. 
RNA was prepared as above except that 5 mM MgCl2 was used in the transcription 
buffer to prevent co-transcriptional splicing. To refold, radiolabeled precursor RNA and 
an internal control RNA in 40 mM Tris-HCl pH 7.5 was heated at 90°C for 1 min 
followed by incubation in 40 mM Tris-HCl H 7.5, 10 mM MgCl2 for 15 min. To initiate 
self-splicing, RNA was mixed with an equal volume of 2X splicing buffer (2 M NH4Cl, 
40 mM Tris-HCl pH 7.5). Reactions were quenched by mixing with an equal volume of 
80% formamide, 100 mM EDTA. Splicing products were resolved using denaturing 4% 
(19:1), 8 M urea, 1X TBE gels, exposed to a storage phosphor screen, and quantitated 
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using Quantity One 1-D Analysis software. All splicing assays were done in triplicate. 
Unequal loading was accounted for by normalizing to an internal control RNA. Band 
intensity was determined by dividing the background-subtracted intensity of each band 
by the number of Us in the RNA sequence corresponding to the band. All band 
intensities were then normalized to an unspliced control to give fractional values of 
input RNA. Rate constants for 5′ splice site cleavage were obtained by fitting plots of 
precursor depletion vs. time to a biphasic exponential equation. Rate constants for the 
second step were obtained by fitting plots of lariat and linear intron accumulation vs. 
time to a biphasic exponential equation. The biphasic nature of the two reactions are 
most likely from two differently folded populations in solution.  
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Chapter 5: Crystal structure of a eukaryotic group II intron 
lariat 
 
5.1 Abstract 
 The formation of branched lariat RNA is an evolutionarily conserved feature of 
splicing reactions for both group II and spliceosomal introns. The lariat is important for 
the fidelity of 5ʹ splice-site selection and consists of a 2ʹ-5ʹ phosphodiester bond between 
a bulged adenosine and the 5ʹ end of the intron. To gain insight into this ubiquitous 
intramolecular linkage, we determined the crystal structure of a eukaryotic group IIB 
intron in the lariat form at 3.7 Å. This revealed that two tandem tetraloop-receptor 
interactions, η–ηʹ and π–πʹ, place domain VI in the core to position the lariat bond in the 
post-catalytic state. On the basis of structural and biochemical data, we propose that π–
πʹ is a dynamic interaction that mediates the transition between the two steps of splicing, 
with η–ηʹ serving an ancillary role. The structure also reveals a four-magnesium-ion 
cluster involved in both catalysis and positioning of the 5ʹ end. Given the evolutionary 
relationship between group II and nuclear introns, it is likely that this active site 
configuration exists in the spliceosome as well. 
 
5.2 Introduction 
 Splicing of nuclear introns results in the formation of circular RNAs1 having a 
branched lariat structure containing an unusual 2ʹ-5ʹ phosphodiester bond2,3. This 
branched RNA product has also been found in group II introns4,5, which are self-splicing 
ribozymes. Defects in lariat formation result in aberrant splicing and human disease6. In 
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higher eukaryotes, splicing of nuclear introns is catalyzed by a large ribonucleoprotein 
complex called the spliceosome, which is thought to share a common ancestor with 
group II introns7,8. 
 Group II introns are catalytic RNAs with six structural domains (Figure 5.1) that 
splice via two trans-esterification reactions. In the first step of splicing, the 2ʹ-OH of a 
bulged adenosine residue is the nucleophile that attacks the 5ʹ splice site to generate 
lariat RNA4,5. In the second step, the 3ʹ-OH of the 5ʹ exon attacks the 3ʹ splice site to 
form ligated exons and excised intron lariat. The highly conserved domain V (DV) 
forms the group II intron active site by binding catalytic metal ions9, and domain VI 
(DVI) contains the bulged adenosine used as the nucleophile in the first step of 
splicing10. 
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Figure 5.1: Secondary structure of P.li.LSUI2 intron crystallization construct. 
Tertiary interactions are indicated with Greek letters and domains are labeled with 
Roman numerals. Colouring of the individual domains is consistent with the overall 
view of the tertiary structure shown in Fig. 5.3. 
 
 Group II introns are divided into three structural classes: IIA, IIB and IIC11,12. 
Historically, the two model systems used to study group II intron structure and function 
have been ‘canonical’ eukaryotic IIB introns: P.li.LSUI2 from the brown algae Pylaiella 
littoralis13 and aI5γ from the yeast Saccharomyces cerevisiae4. However, the only 
available crystal structure is of a IIC representative from the bacterium Oceanobacillus 
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iheyensis9. This idiosyncratic IIC intron class is the most primitive14 and splices through 
hydrolysis to form linear intron15. In contrast, eukaryotic IIA and IIB introns form lariat, 
are evolutionarily later branching14, and therefore more closely related to the 
spliceosome. We targeted the P.li.LSUI2 intron for structure determination since it 
contains a functional DVI that forms large amounts of lariat during splicing13. 
 
5.3 Overall structure 
 Here we present the structure of the P.li.LSUI2 intron in the post-catalytic lariat 
form with ligated exon product at 3.7 Å resolution (Table 5.1) solved using a Yb3+ 
derivative (Figure 5.2). This represents the first crystal structure of a 2ʹ-5ʹ branched 
RNA molecule. 
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Table 5.1: Data collection and refinement statistics 
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Figure 5.2: The Yb-MAD experimental density modified map of the portion of DV 
containing the catalytic triad contoured at 1.8σ. 
 
 Reflecting the ability of IIB introns to form lariat, there are a multitude of unique 
tertiary interactions in the P.li.LSUI2 intron compared to the O. iheyensis structure 
(Figure 5.3). These newly visualized contacts include EBS2–IBS2 (Figure 5.4), µ–µʹ, 
ε-ε′ and the canonical form of κ-κ′. Unlike the O. iheyensis structure, domains II and III 
interact with multiple domains through long-range interactions to stabilize the overall 
fold of the P.li.LSUI2 intron. We can now visualize the location of DVI within the intron 
structure (Figure 5.3 and Figure 5.5), as well as the 2ʹ-5ʹ lariat linkage between the first 
residue and the bulged adenosine. 
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Figure 5.3: A comparison of the tertiary structures of O. iheyensis and P.li.LSUI2 
group II introns. P.li.LSUI2 has a significantly larger and more complex structure with 
a correspondingly greater number of unique RNA tertiary contacts. Domain VI of 
P.li.LSUI2 is highlighted within the box. 
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Figure 5.4: The path of the 5′ exon through the intron structure. The EBS1-IBS1 
and EBS2-IBS2 interactions position the 5′ exon. They do not form a continuous binding 
interface with the presence of a highly distorted backbone at the junction between these 
two motifs. As a result, the helical axes of the EBS1-IBS1 and EBS2-IBS2 pairings are 
positioned ~90° relative to each other. The EBS3-IBS3 interaction places the 3′ exon in 
the active site. 
 
 
 
  
112 
 
 
Figure 5.5: Overall tertiary structure of the P.li.LSUI2 intron. Individual domains 
and subdomains are depicted in different colors. Domain names are labeled with Roman 
numerals. (a) and (b) show different rotations of the intron structure. 
 
5.4 Newly visualized tertiary interactions 
 One of the most highly conserved tertiary contacts in group II introns is the κ–
κʹ interaction between the base of the catalytic DV stem and domain I (DI)16. The 
conserved κ sequence GAA, nucleotide A171 from near the κ region, and residues from 
a GUAAC pentaloop in DIII converge to form a pentuple adenosine base stack 
(underlined residues) that inserts into the minor groove at the base of DV, rigidly placing 
the active site into the DI scaffold (Figure 5.6a and 5.7a). 
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Figure 5.6: Tertiary interactions in a IIB intron. (a) The κ loop (grey) and DIII 
(yellow) converge to form an extended base stack involving five adenosine residues 
inserting into the minor groove of DV (red). (b) G106 and C107 form Watson-Crick 
pairs with C4 and G3 from the 5′ end to form the ε-ε′ interaction that positions the 5′ 
end in the active site. (c) J1/2 (green) interacts with the 5′ end (A6 residue in green), 
DIII (yellow), and J2/3 (blue). (d) DIII (yellow) acts as a brace on the surface of the 
intron and forms three tertiary interactions (boxed) with DI (green), DII (blue) and DV 
(red). 
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Figure 5.7: Companion to Fig. 5.6 showing the location of the individual tertiary 
interactions relative to the overall structure. (a) κ-κ'. (b) ε-ε'. (c) ρ-ρ'. 
 
 The ε–εʹ interaction is critical for catalysis, with disruption through mutagenesis 
resulting in complete loss of splicing activity17. This interaction consists of nucleotides 
G106 and C107 pairing with C4 and G3 from the 5ʹ end of the intron (Figure 5.6b and 
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Figure 5.7b). The end result of these contacts is the formation of five conserved bases 
stacking in the following order (from bottom to top): A573, U2, G5, C4 and G3. This 
serves to structure the 5ʹ end of the intron.  
 The conserved GUAA linker connecting domains I and II (J1/2) adopts an 
unusual backbone configuration that interacts with the 5ʹ end, the junction between 
domains II and III (J2/3), and DIII (Figure 5.6c and Figure 5.7c). The 5ʹ end and J2/3 
directly interact with the active site through J1/2 positioning these regions to stabilize 
the core. This new long-range contact (designated as ρ–ρʹ) consists of two adenosines 
from J1/2 docking into the basal stem of DIII (Figure 5.6c). 
 We can now correlate the function of DIII as a catalytic effector in group II 
introns. DIII interacts with the intron core through the aforementioned GUAAC 
pentaloop, which docks into the base of DV (Figure 5.6d). This µ–µʹ interactionf18 
serves to buttress the opposite side of DV from where catalysis takes place. 
Furthermore, a GAAA tetraloop from DIII interacts with the base of the DII stem 
(designated as τ–τʹ) to provide additional reinforcement. Therefore, DIII functions as an 
external brace located on the outside surface to stabilize the entirety of the structure. 
This important role is consistent with deletion or mutagenesis of this domain rendering 
the intron unstable and not competent for efficient catalysis19. 
 
5.5 DII positions DVI in the active site 
 In the O. iheyensis structure, DII was markedly truncated to a small stem loop 
structure, and in many previous biochemical studies of the aI5γ intron, DII was similarly 
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shortened to study the first step of splicing. We can now visualize the intact DII 
substructure and find that it serves as a central hub for four different tetraloop receptor 
interactions (Figure 5.8a). DII makes contacts with domains I, III and VI to organize a 
large portion of the intron structure. 
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Figure 5.8: The position of DVI within the intron structure. (a) DII forms an inverted 
Y-shaped structure that engages in four distinct tetraloop-receptor interactions with the 
IC stem (orange), DIII (yellow), and DVI (purple). DVI interacts with DII via two 
tandem tetraloop-receptor interactions, η-η′ and π-π′. (b) In vitro self-splicing assays of 
the P.li.LSUI2 intron. The wild-type (WT) intron efficiently catalyzes both steps of 
splicing and forms intron lariat and ligated exons. Mutagenesis of either η-η′ (Δη′)20 or 
π-π′ (Δπ) inhibits the second step, resulting in the accumulation of lariat-3′ exon and 5′ 
exon. A combination of both mutations (Δη′Δπ) nearly blocks the second step of 
splicing with predominantly lariat-3′ exon present. (c) Fo–Fc density for the 2′-5′ lariat 
phosphodiester bond contoured at 3σ. The nucleobase of A615 is disordered and not 
visualized. This map was calculated using a model deleted for A615, G1, and U2 (shown 
in stick format) to avoid model bias. The 5′ (G1) and 3′ (A620) ends form a non-
canonical base pair. 
 
 DII has a ‘Y-shaped’ RNA secondary structure with two stems, D2a and D2b 
(Figure 5.1), coaxially stacking on top of each other such that a tetraloop receptor from 
D2a and a GCAA tetraloop from D2b are facing the same side (Figure 5.8a). This 
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combination provides a binding interface for DVI, which contains both a GAGA 
tetraloop and a tetraloop receptor. Therefore, DVI is tightly placed in the core of the 
intron via two tandem tetraloop receptor interactions with DII. The interaction between 
D2a and DVI is known as the η-η′ contact20 and we are designating the newly discovered 
interaction between D2b and DVI as π–π′. The π–πʹ interaction is especially interesting 
due to its proximity to the bulged adenosine residue A615, which is the nucleophile for 
the first step of splicing. The π tetraloop interacts with nucleotides directly adjacent to 
the bulged adenosine (Figure 5.8a) and therefore probably has important effects upon 
the positioning of this nucleotide within the active site. 
 Mutagenesis of the GNRA tetraloops to UUCG was done to test the effects of 
these two interactions on splicing. Disrupting either contact significantly inhibited the 
second step of splicing, leading to an accumulation of lariat 3′ exon and 5′ exon (Figure 
5.8b and Figure 5.9). However, disrupting both interactions simultaneously resulted in 
a near complete block of the second step. This indicates that π–πʹ and η-η′ are synergistic 
interactions essential for the transition to the second step of splicing and probably 
function through moving the 3ʹ splice site (which is attached to DVI) into the active site. 
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Figure 5.9: Splicing assays for the DVI mutants showing the proportion of 
branched product. Blue and orange bars correspond to lariat-3′ exon and lariat, 
respectively. The Δη′ and Δπ mutants accumulate large amounts of lariat-3′ exon, thus 
indicating a second step splicing defect. The Δη′Δπ double mutant is almost completely 
blocked before the second step. The A620C mutant shows 2.4-fold greater accumulation 
of lariat-3′ exon compared to the WT intron indicating that the interaction between G1 
and A620 is important for the second step. In the yeast aI5γ intron, G1 instead interacts 
with the penultimate residue21, indicating a certain degree of flexibility for this pairing. 
There is evidence for a similar interaction between the termini of nuclear introns22 
involving nearby (but not exactly equivalent) residues, which also has a significant 
effect upon the second step of splicing. Therefore, the 5′ and 3′ ends of nuclear introns 
may have a similar arrangement within the spliceosome. 
 
 We can now visualize the overall fold of DVI embedded within a catalytically 
active intron (Figure 5.8a). DVI contains a purine-rich internal loop, which forms non-
canonical pairings that induce a slight bend in the helix, allowing DVI to simultaneously 
form both the π–πʹ and η-η′ contacts with DII. These interactions position the ribose 
sugar of the bulged A615 directly under the 5ʹ end of the intron. The adenosine in this 
2ʹ-5ʹ lariat linkage is highly constrained, since it is connected to phosphates on three 
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different sides of the nucleotide (Figure 5.10a). The nucleobase component of the A615 
residue is disordered (Figure 5.8c and Figure 5.10b), which is consistent with it not 
having a role in the later stages of splicing. In the current post-catalytic state, the lariat 
phosphodiester bond is located ~20 Å from the active site. Therefore, it has undergone 
a large-scale movement away from the catalytic core after the first step of splicing. In 
close proximity to the lariat bond, the 5ʹ and 3ʹ ends of the intron interact with each other 
through G1 forming a non-canonical base pair with A620 (Figure 5.8c), which is 
important for the second step (Figure 5.9). 
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Figure 5.10: Stereo depiction of the lariat bond. (a) The lariat 2′-5′ phosphodiester 
bond in wall-eyed stereo format. (b) Stereo version of Fig. 3c. See Fig. 3c legend for 
details. Fo-Fc density for the lariat bond contoured at 3σ. 
 
5.6 Active site metal ion configuration 
 Mg2+ ions are an absolute requirement for the catalysis of RNA splicing. To 
identify active site metal ions, soaks were performed using the anomalous scatterer 
Yb3+, which exhibits the same octahedral coordination geometry as Mg2+ and 
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preferentially binds to sites containing highly coordinated magnesium ions9,23. This 
revealed four large anomalous peaks in the ribozyme core (Figure 5.11a). Two of these 
peaks (M1 and M2) are also found in O. iheyensis9 and are embedded within DV to 
coordinate to the junction phosphate between the ligated exons, while the other two 
peaks (M3 and M4) are coordinated to the 5ʹ end of the intron. 
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Figure 5.11: The core of the of P.li.LSUI2 intron. (a) Yb3+ anomalous map (orange 
mesh) contoured at 12σ reveals four large peaks, which correspond to highly-
coordinated magnesium ions (orange spheres). (b) Comparison of the catalytic triplexes 
found in the O. iheyensis and P.li.LSUI2 introns. O. iheyensis contains a continuous 
triple helix spanning between the DV catalytic triad (CGC) and J2/3. In P.li.LSUI2, the 
J2/3 residue A422 is disengaged from the catalytic triad (AGC) and forms a base triple 
with J4/5 and J5/6 nucleotides (U549 and U584, respectively). 
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 M3 is located in a binding pocket formed by the highly conserved 5ʹ end (Figure 
5.12a), which has the sequence GUGCG. Nucleotides in this region exhibit a highly 
contorted backbone configuration that wraps around all sides of M3 due to the ε–εʹ 
interaction involving residues G3 and C4 (Figure 5.6). Therefore, we postulate that the 
primary function of ε-εʹ is to order a crucial metal-binding platform which structures the 
5ʹ end of the intron. 
 M4 coordinates to conserved IIB intron residues A6, C7 and A341 to stabilize 
the 5ʹ end further (Figure 5.12b). These residues are in close spatial proximity to the 
recently proposed ι motif (Figure 5.1) that is known to promote lariat formation and is 
predicted to serve as a receptor for positioning DVI (ref. 24). An ι G79A point mutant 
was crystallized, revealing strong signals for M1 and M2; however, M3 and M4 were 
no longer visible (Figure 5.12c, d). Splicing assays of this mutant also show a negative 
effect on the first step of splicing (Table 5.2). Furthermore, the η–ηʹ interaction, which 
forms the metal-binding platform for M3 and M4, persists throughout group II intron 
catalysis17. Taken together, the data suggest that M3 and M4 participate in the first step 
of splicing by positioning the 5ʹ splice site in the active site to present the scissile 
phosphate to M1, M2 and the bulged adenosine. However, it is possible that M3 exists 
only in the post-catalytic state to stabilize the repositioned lariat bond. Given the rarity 
of highly coordinated magnesium sites in large RNAs25, the existence of four such metal 
ions in close proximity in the active site of P.li.LSUI2 is striking. In addition, we observe 
a conserved monovalent ion near the M1/M2 catalytic center (Figure 5.12e). 
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Table 5.2: Kinetic analysis of P.li.LSUI2 RNA splicing 
 kfast (min−1) kslow (min−1) 
WT 9.51 ± 1.09 0.136 ± 0.0246 
G79A 2.97 ± 1.57 0.0767 ± 0.00942 
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Figure 5.12: Anomalous peaks in the core of the intron. (a) and (b) depict the RNA 
ligands surrounding metals M3 and M4, respectively. Yb3+ anomalous map contoured 
at 9σ. (c) Yb3+ anomalous map for WT contoured at 9σ. (d) Compared with the WT 
intron, the Yb3+ anomalous map for the ι G79A mutant (contoured at 4σ) is lacking the 
peaks corresponding to M3 and M4, even at a lower contour level. (e) Tl+ was used as 
a probe for monovalent ions in the RNA structure26. The Tl+ anomalous map (purple 
mesh contoured at 5.5σ) revealed a strong peak located 3.8 Å from M1 that coordinates 
to the nucleobase of J2/3 residue G421 and the backbone of DV nucleotide G550. This 
sodium ion Na1 (purple sphere) is significantly closer to M1 than the equivalent K+ ion 
found in O. iheyensis25. Otherwise, this monovalent ion binding site is relatively 
conserved between these two introns. 
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5.7 Catalytic triplex rearrangement 
 In the O. iheyensis structure, J2/3 and residues from DV form a catalytic triplex 
structure essential for the catalysis of splicing and that is also found in the 
spliceosome27. In the O. iheyensis triplex, J2/3 residues G288 and C289 (analogous to 
G421 and A422 in P.li.LSUI2) form base triples with the first two nucleotides of the 
catalytic triad. Unexpectedly, we observe in the P.li.LSUI2 structure that one of the J2/3 
residues is completely disengaged from the catalytic triad. Specifically, A422 has 
moved away from the triad and stacks directly underneath the base of the DV helix to 
form a base triple with residues from the J4/5 and J5/6 linkers (Figure 5.11b). The 
possibility of J2/3 participating in conformational changes has been previously 
postulated28. However, we can now see the specific nature of this ‘switch’ with the 
disengagement of J2/3 from the catalytic triad into an alternate configuration. The 
linkers between domains are highly conserved for each subclass of group II introns, and 
based on the P.li.LSUI2 structure we hypothesize that they are dynamic and modulate 
splicing. 
 
5.8 π-π' is a dynamic interaction 
 DVI is proposed to engage in large-scale conformational changes between the 
two steps of splicing20,24. To test this model, a catalytic triad mutant (AGCàGAU) 
inactive for splicing was crystallized and solved at 7 Å (Figure 5.13). Strong electron 
density was observed for the η–ηʹ interaction between DII and DVI, indicating that this 
contact persists throughout both steps of splicing and that there is no large-scale change 
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in DVI position. Therefore, a new model is required to explain how DVI mediates the 
transition between the two steps of splicing. 
 
 
 
Figure 5.13: 2Fo-Fc density for DVI in the pre-catalytic structure contoured at 1σ. 
The η-η’ interaction persists throughout the splicing reaction and is visible in the pre-
catalytic state. The weaker density for the central region of DVI suggests a partially 
disordered, dynamic region with possible helical remodeling in the conserved internal 
loop during splicing. The general pattern of side-by-side packing of domains II and VI 
persists between the two steps. Catalytic triad mutation consisted of an AGC→GAU 
substitution. 
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 During the first step, the bulged adenosine must be in close proximity to M1, 
M2 and the 5ʹ splice site to engage in nucleophilic attack. However, π–πʹ places the 
bulged adenosine ~20 Å from the active site in the post-catalytic structure. Mutagenesis 
of π–πʹ also has no significant effect on the first step of splicing (Figure 5.8b), and is 
unlikely to be engaged for lariat formation. Furthermore, DII is likely to remain largely 
stationary during catalysis due to the strong anchoring effect of multiple tetraloop 
receptor interactions with this domain. On the basis of these observations, we propose 
that π–πʹ is a dynamic interaction that toggles DVI between two different states to 
mediate the transition between the first and second steps of splicing (Figure 5.14). In 
the first step, the bulged adenosine is engaged in the active site for nucleophilic attack 
at the 5ʹ splice site. At this stage, π–πʹ exists in the ‘off’ state where DII is disengaged 
from the base of DVI. The DVI helix would also presumably exist in a relaxed 
conformation due to the lack of constraint provided by π–πʹ. Following lariat formation, 
DVI probably engages in remodeling of its central internal loop adjacent to A615, 
causing helical compression to turn ‘on’ the π–πʹ interaction, thus sequestering the 
bulged adenosine away from the active site. A second possible model is that the base 
pairs between the G6 sequence (residues 588 to 593) and a pyrimidine-rich tract (612 to 
614; 616 to 618) at the proximal side of the DVI stem rearrange to reposition the lariat 
phosphate and engage π–πʹ. Both models serve to empty the active site of the 5ʹ end and 
allow entry of the 3ʹ splice site, which is directly attached to the end of DVI. In fact, the 
primary function of the lariat may be to covalently attach to the 5ʹ end to provide an 
attachment point for this pulling action. 
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Figure 5.14: Model for DVI as the conformational switch for splicing. π-π’ mediates 
the transition between the two steps of catalysis. See text for details. 
 
5.9 Evolutionary implications 
 This bulged adenosine of DVI is analogous to the branch site adenosine in 
spliceosomal introns. The branch site sequence UACUAAC (nucleophilic adenosine 
underlined) pairs to the U2 snRNA to extrude the adenosine from the helix29 as in DVI. 
Owing to the mechanistic and evolutionary similarities with group II introns, it is likely 
that the branch site adenosine residue and the 5ʹ end of nuclear introns will adopt a 
similar spatial arrangement relative to the catalytic core of the spliceosome. We predict 
that the spliceosomal branch site adenosine will be sequestered after the first step of 
splicing with an RNA and/or protein contact analogous to the π–πʹ interaction in 
P.li.LSUI2. In fact, an interaction observed between a region just downstream of the 
branch site and the U5 snRNA loop may be the spliceosomal counterpart of π–πʹ30. 
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 The P.li.LSUI2 structure provides a rationale for the phylogenetic conservation 
of the 5ʹ end. Group II introns have the consensus sequence GUGYG (where Y = U or 
C)11, which is similar to the GUAYG and GURAG (where R = G or A) sequences found 
at the 5ʹ ends of yeast and mammalian introns, respectively31. In the spliceosome, the 
U6 snRNA pairs with the 5ʹ end32 in an analogous manner to the ε–εʹ interaction in 
group II introns. Therefore, these conserved sequences probably form a similar metal-
binding platform in spliceosomal introns, with the 5ʹ end forming a highly distorted 
backbone to coordinate magnesium ions that orient the splice site in the core. 
 In regards to the evolutionary rationale for the 2ʹ-5ʹ phosphodiester bond, it is 
known that the lariat is required for full reversibility of group II intron splicing33. These 
reverse splicing reactions are the mechanism through which group II introns are able to 
invade DNA34 and disperse throughout genomes. It is likely that the lariat bond pre-
organizes the core of the intron structure to facilitate this reversibility. Reverse splicing 
has also been proposed as a vehicle for the prolific expansion of nuclear introns35, which 
comprise ~25% of mammalian genomes. There is biochemical support for this 
hypothesis in that the spliceosome has recently been shown to catalyze reverse splicing 
reactions36. The lariat probably has a similar role in spliceosomal introns by allowing 
reverse splicing to occur, thus accounting for its phylogenetic conservation across the 
kingdoms by enabling ‘selfish introns’ to replicate. Therefore, the P.li.LSUI2 crystal 
structure has provided the first glimpse of the branched lariat linkage that was probably 
crucial for intron proliferation in eukaryotes. 
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5.10 Methods 
Cloning and preparation of Pylaiella littoralis LSU I2 intron RNA 
 DNA was synthesized (Genscript) corresponding to the second intron 
interrupting the large ribosomal subunit (LSU) in the mitochondria of the brown alga 
Pylaiella littoralis (P.li.LSUI2). The crystallization construct contains a 15-nt 5′ exon 
and a 5-nt 3′ exon followed by a Hind III restriction site. The DIV open reading frame 
(ORF) was removed from the P.li.LSU2 intron and replaced with a UUCG stem 
tetraloop. This was cloned into the EcoRV site of pUC57. Plasmid was linearized by 
HindIII digestion prior to in vitro transcription. Non-conserved loops in domain 1, 2 and 
4 were changed from the wild type sequence. Most significantly, changing the sequence 
UAUUUAUA to UCGACAUAAGG in the ID2 stem loop improved both crystallization 
rate and diffraction. The final construct retained wild-type splicing activity. 
Transcription was performed overnight at 37°C using T7 RNA polymerase in 25 mM 
MgCl2, 2 mM spermidine, 5 mM DTT, 40 mM Tris-HCl pH 7.5, 0.05% Triton X-100, 
2.5 mM of each NTP, and thermostable inorganic pyrophosphatase (New England 
Biolabs). CaCl2 was added to a final concentration of 1.2 mM, treated with DNase I for 
45 minutes, followed by proteinase K digestion for 1 hour. The intron reacted to 
completion during in vitro transcription and was subjected to a native purification 
procedure previously used in the structure determination of the O. iheyensis intron9. 
Spliced intron RNA was repeatedly washed with 10 mM MgCl2 and 5 mM sodium 
cacodylate pH 6.5 and concentrated to 10 mg/ml using a 100 kDa molecular weight cut-
off Amicon Ultra-15 column. 
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Crystallization 
 The native crystals were grown in sitting drops by vapor diffusion at 30°C. Equal 
volumes of RNA (10 mg/ml) were mixed with 0.4 mM spermine, 21% 2-Methyl-2,4-
pentanediol (MPD), 175 mM magnesium acetate tetrahydrate, and 90 mM MES 
monohydrate (pH 5.6). Rod-like crystals appeared within two days, and grew to a 
maximum size of 50×50×900 µm. Crystals were gradually exchanged into 21% MPD, 
100 mM magnesium acetate tetrahydrate, 50 mM MES monohydrate (pH 5.6), 3 mM 
iridium hexammine, 0.5 mM spermine, and 100 mM NaCl; followed by flash freezing 
in liquid nitrogen. Iridium hexammine was used as an additive for the native crystals as 
it reduced mosaicity. Pre-catalytic intron RNA was obtained by mutating the AGC 
catalytic triad of DV to GAU. The mutation maintained stem pairing but completely 
inhibited splicing activity. Crystallization of this mutant was done by microseeding 
under conditions described above. The ι G79A mutant crystallized in 0.2 M ammonium 
acetate, 10 mM calcium chloride, 50 mM sodium cacodylate pH 6.5, and 10% w/v 
polyethylene glycol 4000. Resulting crystals were cryoprotected through gradual 
transfer to the crystallization solution supplemented with 30% ethylene glycol. 
Structure determination 
 The crystal structure of the P.li.LSUI2 intron was solved at 3.7 Å resolution 
using multi-wavelength anomalous dispersion (MAD) with crystals soaked in 0.5 mM 
ytterbium (III) chloride. Yb3+ soaks were performed in 21% MPD, 100 mM magnesium 
acetate tetrahydrate, 50 mM MES monohydrate (pH 5.6), 0.5 mM spermine, 100 mM 
NaCl, and 0.5 mM YbCl3 for 3 hours at room temperature. Tl+ soaks were performed 
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in the same manner with 10 mM thallium acetate. X-ray data sets were collected at NE-
CAT’s 24-ID-C beamline at the Advanced Photon Source (Argonne National 
Laboratory, Argonne, Illinois). Data was processed using HKL-200037, heavy metal 
sites were identified with SHELXD38 and phasing done using Phenix39 and SHELXE40. 
RNA nucleotides were modeled using COOT41 and the RCrane plugin42. The 
phylogenetically predicted secondary structure (Figure 5.1) guided modeling into the 
electron density. Structure refinement was done using Buster43, Phenix39, DEN44, and 
Phenix.Erasser45. The 2′-5′ phosphodiester bond was restrained using a cif restraint file 
in phenix.refine. All software was compiled by SBGrid46. 
In vitro self-splicing assays 
 The construct used for the in vitro self-splicing assays contained wild-type 
P.li.LSUI2 sequence with DIV ORF removed and a 250-nt 5′ exon and 75-nt 3′ exon. 
This was cloned into the pUC57 plasmid. Plasmid was linearized using HindIII and used 
for in vitro transcription with T7 RNA polymerase. Radiolabeled transcripts were 
prepared as above using 10 µCi [α-32P] UTP (3000 Ci/mmole), 0.5 mM UTP, 1 mM 
other NTPs, and 10mM MgCl2. Transcripts were gel purified on a 4% polyacrylamide 
(19:1)/8 M urea gel, RNA was recovered by diffusion into 300 mM NaCl, 0.01% SDS, 
1 mM EDTA. Self-splicing experiments were performed for 30 min at 45°C in a splicing 
buffer containing 10 mM MgCl2, 1M NH4Cl, 40 mM Tris-HCl (pH 7.5), and 0.02% 
SDS. Reactions were stopped by addition of EDTA to a final concentration of 20 mM. 
Splicing products were resolved using a denaturing 4% polyacrylamide (19:1)/8 M urea 
  
135 
gels. Rate constants for the WT and G79A mutant were derived from curves fit to a 
biphasic exponential equation. All splicing assays were done in triplicate. 
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Chapter 6: Conclusion 
 
6.1 Introduction 
 Group II introns are self-splicing ribozymes found in all three domains of life. 
They are predominantly found in bacteria as well as in the mitochondria and 
chloroplasts of some eukaryotes, and rarely in archaea1. The secondary structure of 
group II introns can be subdivided into six domains that fold into an ordered three-
dimensional structure that catalyzes splicing via two transesterification reactions. In the 
first step, the 2′-hydroxyl of a bulged adenosine in domain VI attacks the 5′ splice site 
resulting in the formation of a branched RNA containing a 2′-5′ phosphodiester bond 
(known as the ‘lariat’) and a free 3′-hydroxyl of the newly cleaved 5′ exon2,3. In the 
second step, this 3′-hydroxyl attacks the 3′ splice site resulting in ligated exons and the 
release of intron lariat. The stereochemistry of this reaction is identical to that seen in 
the spliceosome, which removes nuclear introns from pre-mRNAs. The group II intron 
and spliceosome are postulated to share a common ancestor based on similarities in 
conserved core RNA structures and mechanism. Recent biochemical evidence has also 
shown that the spliceosome is a ribozyme that uses a two-metal-ion mechanism of 
catalysis4. Two spliceosomal RNAs, U2 and U6, comprise the active site and are capable 
of performing a splicing-related reaction in the absence of spliceosomal proteins5,6.  
 Of the three structural classes of group II introns (IIA, IIB, and IIC), IIC introns 
are thought to be the most primitive7. IIA and IIB introns typically form large amounts 
of lariat RNA during in vitro self-splicing reactions, whereas IIC introns primarily splice 
through hydrolysis in vitro to form linear intron8. Previously, a crystal structure of a 
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hydrolytic IIC intron from the bacterium Oceanobacillus iheyensis (O. iheyensis) 
revealed that the highly conserved DV forms an active site containing two catalytic 
magnesium ions9. However, this structure lacked domain VI (DVI), which contains the 
bulged adenosine nucleophile required for lariat formation in the first step. The recent 
crystal structure of a post-catalytic, eukaryotic group IIB intron from the brown algae 
Pylaiella littoralis (P.li.LSUI2) contains a functional DVI10. Given that this intron 
catalyzes lariat formation11, it has contributed to a new understanding of the structural 
requirements for splicing in higher eukaryotes. 
  
6.2 Newly visualized DVI 
 DVI contains the bulged adenosine residue analogous to the branch site 
adenosine found in spliceosomal introns. Given its importance in lariat formation, the 
location and orientation of DVI within the group II intron has been a long-standing 
question in the field of RNA splicing. There have been several proposed models for 
DVI, with some postulating a side-by-side packing with the catalytic DV, and others 
placing DVI at ~90˚ from DV in the first step12,13. The structure of the intron lariat 
finally allowed visualization of DVI and the tertiary interactions that position it in the 
catalytic core. In this structure, the two distal stems of domain II (DII), D2a and D2b, 
coaxially stack and form two tetraloop-receptor interactions with DVI (Figure 6.1a). 
The GAGA tetraloop in DVI docks into the receptor at the base of D2a (η-η′), and the 
GCAA tetraloop in D2b docks into a receptor directly adjacent to the bulged adenosine 
in DVI (π-π′). These two tetraloop-receptor interactions position DVI in the core of the 
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intron at a ~180˚ angle from DV in a conformation in which these two helices are not 
coaxially stacked on each other (Figure 6.1b). Mutagenesis of either of these GNRA 
tetraloops to a non-interacting UUCG results in an accumulation of intermediate 
splicing products consisting of lariat-3′ exon and 5′ exon. Furthermore, a construct 
containing both mutated tetraloops results in an almost complete block of the second 
step10. The discovery of the π-π′ interaction is interesting due to its proximity to the 
bulged adenosine residue A615. This interaction provides the means for removal of the 
lariat bond from the active site after the first step to allow entry of the 3′ splice site for 
the second step.  
 
Figure 6.1: Overall tertiary structure of P.li.LSUI2. (a) Interactions between DII and 
DVI. The two distal stems of DII (blue) coaxialy stack and align parallel to DVI 
(purple). The two tetraloop-receptor interactions between domains II and VI, η-η' and 
π-π', are indicated with black boxes. Individual domains and subdomains are shown in 
different colors. (b) Arrangement of DV and DVI. DV (red) and DVI (purple) are 
oriented 180˚ relative to each other. The image on the left shows the two domains from 
the same angle as (a). The image on the right is rotated 90˚ about the y-axis to show that 
the two domains are not coaxially stacked. G1 is shown in green and interacts with 
A620.  
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 Previous models proposed a large-scale “swinging-arm” movement of the distal 
end of DVI (containing the tetraloop) with η-η′ being disengaged for the first step of 
splicing12,13. However, the pre-catalytic state of P.li.LSUI2 at 7 Å revealed strong 
electron density for the η-η′ interaction10, demonstrating that this contact persists 
through both steps of splicing and suggesting that large scale movement of DVI is 
unlikely. Therefore, we propose a more subtle conformational change in which DVI 
remains 180˚ from DV with π-π′ being disengaged for the first step of splicing and 
engaged for the second step. This allows the bulged adenosine to reach the active site in 
the first step. Upon lariat formation, π-π′ engages, removing the bulged adenosine from 
the active site while simultaneously pulling the attached 3′ splice site into the core.   
 An analogous interaction sequestering the adenosine nucleophile after the first 
step likely exists in the spliceosome. A possible spliceosomal counterpart could be an 
RNA-RNA interaction between the U5 snRNA and a region just downstream of the 
branch site14. However, this may also be accomplished via an RNA-protein interaction.  
Another possibility for a π-π′ analogue is the spliceosomal p14 protein, which crosslinks 
directly to the branch site adenosine15. It has been proposed that this RNA-protein 
interaction must be disrupted to allow for the first step of splicing16,17, in a manner 
similar to π-π′. The conserved protein Prp8 could be yet another candidate for engaging 
in an equivalent π-π′ interaction since it has been also shown to crosslink to the branch 
site as well as other key regions in the spliceosomal core, such as the 5′ and 3′ exons18–
20. Mutations in RNA binding regions of Prp8 result in both first and second step defects, 
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indicating an essential role in positioning substrates in the active site21. There is also 
structural evidence suggesting that Prp8 is derived from a group II intron encoded 
protein (IEP), also known as a maturase22. Maturases assist in the proper folding of 
group II introns in vivo1. In a similar manner, Prp8 likely functions as an assembly 
platform in the spliceosome to mediate intron removal by snRNAs. 
 
6.3 Active site dynamics 
 In previous IIC intron structures, the single-stranded linker between domains II 
and III (J2/3) forms base triple interactions with catalytic residues from DV9,23. There 
is also evidence for similar base triples in the active site of the spliceosome24. 
Interestingly, in the P.li.LSUI2 structure, one of the J2/3 residues (A422) is not engaged 
in a base triple with the catalytic triad, as was previously observed in the IIC structures. 
Instead, A422 is forming a base triple with residues from J4/5 (U549) and J5/6 (U584) 
(Figure 6.2). This newly observed interaction of A422 introduces the possibility that the 
triple helix architecture in the catalytic core may change configuration between the two 
steps of splicing. Additionally, 7-deaza, 2,6-diaminopurine, and N6-methyl NAIM 
interferences were observed for the yeast aI5γ intron residue equivalent to A42225. 
However, only the N6 amino group of A422 interacts with nearby bases in the post-
catalytic P.li.LSUI2 structure, suggesting that this nucleotide may engage in additional 
transient interactions during the splicing reaction. Therefore, the observation that 
additional functional group identities of residue A422 are important supports the 
hypothesis of a dynamic role for the J2/3 linker between splicing steps likely modulating 
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catalysis. This hypothesis is also supported by crystal structures of the IIC intron 
showing that J2/3 disengages from the catalytic triad in the transition from the first to 
second step23. J4/5 and J5/6 are also likely intimately involved in conformational 
rearrangements within the catalytic triad in supporting roles for J2/3. A similar 
interaction(s) may also be occurring within the spliceosome. Mutagenesis of the U584 
analogue in yeast (A25 in U2 snRNA) resulted in a 50% decrease in efficiency of the 
second step26. Therefore, A25 plays a similar role in the second step as U584 in the 
P.li.LSUI2 intron. The lack of a first step splicing defect upon mutagenesis of A25 
suggests that rearrangement of the base triples occurs in the transition between the two 
steps. This also alludes to the possibility that every stage of catalysis may have a unique 
arrangement of base triples in the catalytic core.  
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Figure 6.2: P.li.LSUI2 core interactions and the proposed analogous spliceosomal 
residues. Coloring is consistent with the domains in Figure 6.1. P.li.LSUI2 residue 
numbers are shown in red, blue, and tan with proposed analogous U2 and U6 numbering 
in black. Spliceosomal numbering is from S. cerevisiae. In P.li.LSUI2, J2/3 residue 
A422 is disengaged from the catalytic triad (AGC) and instead forms a base triple with 
residues U549 and U584. Catalytic metals are shown as orange spheres and labeled M1 
and M2.  
 
6.4 3′ splice site selection in the second step 
 The EBS1-IBS1 and EBS2-IBS2 interactions in IIB introns function to correctly 
place the 5′ splice site in the active site for the first step. As is seen in the P.li.LSUI2 
post-catalytic structure, these interactions remain engaged through the second step to 
position the 3′-OH nucleophile of the 5′ exon in the active site for the second step. It has 
been previously shown that deleting EBS1 from a group IIB intron and loop 1 from the 
U5 snRNA in yeast spliceosomes both result in an accurate and efficient first step, but 
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stalling of the second step27,28. This stalling can be relieved in group II introns upon the 
addition in trans of EBS1 or snRNA U5 loop 127. This suggests that both elements have 
a similar function in the group II intron and the spliceosome to tether the free 5′ exon to 
the active site between the two steps of splicing. The U5 snRNA has also been shown 
to base pair with the first two nucleotides of the 3′ exon (Figure 6.3a)29,30. This 
interaction is equivalent to the EBS3-IBS3 interaction in group II introns (Figure 6.3b) 
that forms prior to the second step to aid in the placement of the 3′ splice site, thus 
further extending the parallels between the two splicing systems.  
 
 
 
Figure 6.3: Comparison of spliceosomal and group II intron core structures prior 
to the second step. Analogous residues are shown in the same color and the color 
scheme is from ref. 10. DV residues are shown in red, J2/3 in blue, J4/5 in tan, EBS1 in 
light blue, EBS3 in gray, ε in orange, ε' in green, and γ' in purple. The conserved branch 
point residue is circled in red. Dotted gray lines denote base triples, solid black lines 
designate base pairing, the dashed black line indicates the γ- γ' base pair, and the thick 
black line represents the 2'-5' bond between the branch point residue and the first residue 
of the intron. Numbering is as in Figure 6.2. (a) Predicted spliceosomal core elements. 
Numbering is according to the S. cerevisiae U2 and U6 sequences. The intron is shown 
as a thick gray line. (b) Group II intron core arrangement. Numbering is as in Figure 
6.2.  
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 Prior to the second step, the γ-γ′ interaction must also form in group II introns to 
aid in positioning of the 3′ splice site. This highly conserved contact forms between the 
last nucleotide of the intron and the residue immediately 5′ to the J2/3 residues 
participating in base triples with the catalytic triad. This interaction brings the 3′ splice 
site in close spatial proximity to the catalytic metals in DV. In the post-catalytic 
P.li.LSUI2 structure, γ-γ′ is found to be disengaged indicating that it is a transient 
interaction that only exists during the presentation of the scissile phosphate of the 3′ 
splice site to the catalytic metals. Furthermore, the structure reveals a non-canonical 
pairing between the highly conserved G1 residue from the 5′ end and A620, which is 
the third nucleotide from the 3′ end of the intron. Therefore, the combination of both γ-
γ′ and G1-A620 cooperate to precisely position the 3′ splice site within the core. In this 
case, the terminal nucleotides are not in direct contact with each other.  However, in the 
spliceosome, it has been observed that the last nucleotide of the intron forms a non-
canonical G-G base pair with the first nucleotide31,32. As a result, the functions of γ-γ′ 
and G1-A620 are combined into a single entity involving direct interaction between the 
5′ and 3′ ends.  
 Atomic resolution spliceosome structures immediately after branching33,34 (C 
complex) and directly preceding exon ligation35,36 (C* complex) reveal an additional 
conserved architectural feature with group II introns. Because the same active site is 
utilized for both steps of splicing, first-step products must be removed from the active 
site after branch formation before exon ligation can take place. In group II introns, this 
rearrangement is likely promoted by dynamic contacts within DVI10. As the 
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spliceosome does not contain an analogous DVI, and therefore p-p′, proteins have 
evolved to take over the role of displacing the bulged adenosine from the active site. 
Despite the different means of transitioning from branching to exon ligation, the 
distance the bulged adenosine is removed from the active site remains consistent (Figure 
6.4). This conservation of bulged adenosine displacement distance is additional 
evidence of an evolutionary link between group II introns and the spliceosome. 
 
 
Figure 6.4: Comparison of group II intron and spliceosome active sites immediately 
preceding exon ligation. In the P.li.LSUI2 lariat-3′ exon crystal structure, the 
conserved adenosine is located ~20 Å away from the catalytic metal ions in the active 
site. The same distance is observed in the spliceosome C* complex at the same stage of 
splicing (PDB: 5MPS).  
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6.5 Future Directions 
 The crystal structure of the P.li.LSUI2 intron in the post-catalytic lariat and 
intermediate lariat-3′ exon forms have advanced our understanding of the structural 
requirements for group II intron splicing. However, this only represents the end product 
state and does not capture the entire spectrum of intermediates along the splicing 
pathway. For example, the pre-catalytic state would reveal the rationale for the 
conservation of the bulged adenosine nucleophile between group II introns and the 
spliceosome. At this stage of splicing, there must exist a defined binding pocket for this 
nucleobase that precisely positions the 2′-OH of the ribose sugar directly above the 5′ 
splice site. This structure would also reveal the specific nature of the conformational 
rearrangements involving DVI. Given that the distal tetraloop of DVI forms the static 
η-η′ interaction, the proximal region containing the bulged adenosine must either 
unwind or shift in order to engage π-π′ for the second step. Another intermediate of 
interest is the state prior to the second step of splicing, in which the 5′ exon is poised to 
attack the 3′ splice site. These intermediates may yet reveal additional unique catalytic 
triplex configurations for each stage of splicing. These base triple rearrangements would 
not be captured in the truncated IIC intron structure given that it was missing J5/6 and 
DVI. The triplex may have a similar dynamic nature in the spliceosome and assist with 
the forward progression of splicing.  
 The crystal structure of Prp8 has unexpectedly revealed an RT-like fold similar 
to that expected for group II intron maturases, with Prp8 forming a cavity for the binding 
of the catalytic U2/U6 snRNA22. The next major goal is to determine the structure of a 
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group II intron ribonucleoprotein (RNP) complex containing the cognate maturase. This 
protein facilitates splicing and allows retrotransposition reactions to occur in which the 
group II intron is able to insert into double-stranded DNA targets1. The structure of a 
group II intron RNP would also allow a direct comparison with Prp8 to definitively 
establish structural homology. There is now increasing evidence that group II introns 
and the spliceosome share a common ancestor. These advancements in the study of 
group II intron structure and function can now be applied to further our understanding 
of the nuclear splicing machinery through investigation of the analogous interactions in 
the spliceosome. 
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